MPJE Practice Test

Multistate Pharmacy Jurisprudence Examination (MPJE)

MPJE overview

  • 199 practice questions
  • 32 flashcards
  • 6 study guide topics
  • 40 key terms

What you'll study

  • Federal statutes, regulations, and agency guidance affecting pharmacy practice25%
  • Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance25%
  • Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements15%
  • Prescription processing, dispensing, labeling, counseling, and patient care obligations15%
  • Licensure, registration, certification, and pharmacy operations/inventory management10%
  • Compounding, nonprescription and behind-the-counter products, and special distribution channels10%

The Multistate Pharmacy Jurisprudence Examination (MPJE) is the pharmacy law licensure examination: it tests federal statutes and regulations layered on top of the statutes, board rules, and regulatory guidance of one specific jurisdiction. Candidates for pharmacist licensure in most U.S. jurisdictions must pass both a clinical examination and a jurisprudence examination, and the MPJE is the jurisprudence component most boards use. It is administered by the National Association of Boards of Pharmacy, an organization independent of this page.

Because the exam is jurisdiction-specific, you register for a particular state or territory, and the items test that jurisdiction's law alongside federal requirements. Two candidates sitting on the same day may see substantively different content. That makes the MPJE less about memorizing one national body of law and more about knowing where federal requirements end and state rules begin, and which rule controls when the two diverge.

The exam is computer-delivered at a commercial testing network and consists of multiple-choice questions. NABP publishes the current item count, appointment length, fee, and passing standard on its website; those figures are revised periodically, so confirm them there before you schedule.

Preparation is usually self-directed: read the federal statutes and regulations, then the target state's pharmacy practice act and board rules, then work scenario-based questions. Most candidates find state law consumes the majority of study time, because that is where the surprises live.

Common mistakes

Answering a question with the federal requirement whenever the candidate knows it, without first asking whether the state rule is stricter - e.g., saying a Schedule II prescription has no expiration date, or that a pharmacist may counsel by 'offer' only, when the candidate's state imposes a 30-day fill window or mandatory counseling.

Federal law gets the most study hours and feels like 'the' answer; state content is learned late and stored as a separate, fuzzy list, so under time pressure the federal rule surfaces first and feels safe.

What to do instead

For every rule you memorize, force a two-column federal/state comparison and write 'stricter = answer' at the top of the state column. Practice by rewriting each federal rule you learn into the sentence 'Unless my state requires more, ___' and then filling in the state's actual requirement.

Skipping agency guidance as 'not real law' - never reading FDA guidance documents, DEA registration FAQs/letters, or board newsletters and policy statements, then missing items that test those documents rather than the statute text.

Candidates classify material as 'statute/regulation (testable)' versus 'guidance (fluff)', so guidance topics get zero study time even though board exams routinely draw items from them.

What to do instead

Add a guidance column to your outline for each domain and list the specific documents your board references (compounding guidance, registration guidance, board policy statements). Label each as binding or advisory so you can answer both 'what is required' and 'what is recommended' questions correctly.

Blending controlled substance rules across schedules - allowing refills on a CII, transferring a CIII–V prescription more than once or without a shared real-time database, filling a partial CII beyond the allowed window, or forgetting the 7-day written follow-up after an emergency oral CII.

The rules are taught as a narrative ('controlled substances generally...'), so the CII exceptions and the CIII–V permissions bleed into each other; the brain stores one blended 'controlled substance rule' instead of five schedule-specific rules.

What to do instead

Build one matrix with a column per schedule (II, III, IV, V) and a row for each mechanic: refills allowed, total validity, partial fills and time limits, emergency oral follow-up, transferability, fax/electronic acceptance. Reconstruct the matrix from memory daily until every cell is schedule-specific, not 'generally'.

Treating one DEA registration as covering multiple locations or activities, and misusing Form 222 - using a 222 form for Schedule III–V drugs, assuming a power of attorney can be given to an unregistered person, or assuming an agent's signature is valid without a valid POA on file.

Registration and ordering are studied as a single 'paperwork' topic instead of as location-specific and activity-specific permissions, and the 222 form is memorized as 'the controlled substance order form' without its schedule limit.

What to do instead

Memorize registration as 'one registration per location, per activity' and state license as a separate, independent requirement. For ordering, drill the single rule: Form 222 is for Schedule I and II only; power of attorney is executed by the registrant, kept on file, and may only be granted to a person who is authorized to sign for that registrant.

Mishandling controlled substance recordkeeping - describing the biennial inventory as 'twice a year', estimating counts for Schedule II, discarding records before two years, or reporting a theft as a police matter only without filing the DEA theft/loss form.

'Biennial' and 'biannual' are easily confused, and inventory is learned as a vague 'do an inventory' concept without exact-count rules, retention periods, or the specific reporting forms attached.

What to do instead

Anchor the facts with a small card: biennial = every two years; exact count for Schedule II, estimated count permitted for III–V (exact if the container holds more than 1,000 units); records kept two years; theft or significant loss reported on DEA Form 106, destruction documented on DEA Form 41. Test yourself with 'what form, what interval, how long kept' until all three are automatic.

Producing an incomplete label - omitting the federal transfer warning on a Schedule II label, omitting the expiration date or pharmacy/prescriber identifiers, or forgetting state-mandated auxiliary labels and state-specific wording.

Candidates memorize 'label = name, address, drug, directions' from a dispensing workflow, not from the regulation's required-element list, and state additions are studied separately from federal ones.

What to do instead

Memorize the required-element list as a numbered checklist and rehearse it aloud for a CII and a non-controlled dispensing scenario side by side. Explicitly note which elements are federal and which your state adds (auxiliary labels, expiration dating, prescriber identifier format).

Satisfying the counseling obligation by documenting an 'offer to counsel' when the state requires actual counseling, or failing to document patient refusal when the state requires it - and not distinguishing in-person counseling from written information requirements.

OBRA-90's 'offer to counsel' is the version most candidates learn, so it gets treated as the universal rule; state variations and documentation requirements are learned as an afterthought.

What to do instead

Learn the counseling rule as a three-part structure - federal baseline (offer), state baseline (offer vs. must counsel, and to whom), documentation (refusal or provision) - and memorize your state's exact wording. Rehearse one scenario where the patient declines and state what you record and where.

Assuming a pharmacist or pharmacy licensed in one state may serve patients elsewhere - dispensing into a state without a nonresident pharmacy registration, assuming pharmacist licensure transfers by reciprocity without an application, or making a change of pharmacist-in-charge or ownership without notifying the board.

Licensure is studied once as 'get a license', so ongoing operational obligations (nonresident registration, PIC changes, ownership changes, required signage/references) are treated as administrative trivia rather than exam-tested requirements.

What to do instead

Build a licensure lifecycle list: initial licensure, reciprocity/score transfer, nonresident registration for out-of-state dispensing, PIC change, ownership change, and required notifications with their time limits. For each, write 'who notifies whom, on what form, within how many days'.

Crossing the 503A/503B boundary - assuming a 503A pharmacy may compound regularly from bulk substances not on the 503A list, that an outsourcing facility may use the 503A bulks list, or that a 503A compound may be 'essentially a copy' of a commercially available product without the required prescriber determination; also applying the wrong beyond-use date framework.

Both pathways are taught as 'compounding', so the distinguishing criteria (prescription-based vs. outsourcing, bulks list used, cGMP, BUD rules) collapse into one fuzzy rule set.

What to do instead

Memorize a two-column comparison: 503A (patient-specific prescription or a limited anticipatory basis, state board oversight, 503A bulks list, cannot essentially copy a commercially available drug absent a prescriber-determined significant difference) versus 503B (registered outsourcing facility, cGMP, 503B bulks list, adverse event reporting). Then attach the correct beyond-use date standard (sterile vs. nonsterile) to each column.

Handling a pseudoephedrine/ephedrine sale without applying the behind-the-counter mechanics - exceeding the daily or 30-day quantity limit, selling to a purchaser under 18, failing to require photo ID and log the sale, or confusing the retail limits with the mail-order limit.

These products are shelved as 'OTC' in the candidate's mind, so the logbook, ID, age, and quantity rules are understudied and the daily and monthly numbers get swapped.

What to do instead

Memorize a compact card: daily limit, 30-day limit, a different limit for mail-order, minimum age, photo ID, written or electronic logbook, and the seller's self-certification obligation. Practice with one 'how many can this patient buy today' calculation so the daily versus 30-day distinction is automatic.

Exam requirements can change. Confirm current details with the exam provider.

MPJE practice

199 questions. Each one lists the choices, the correct answer, and an explanation. With JavaScript, this list opens one question at a time. The checker at the top of this page saves progress in this browser when it is available.

  1. Question 1Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A drug has a high potential for abuse, no currently accepted medical use in treatment in the United States, and lacks accepted safety for use under medical supervision. Under the Controlled Substances Act, this drug is placed in which schedule?

    1. Schedule I Correct answer.
    2. Schedule III
    3. Schedule II
    4. Schedule IV

    Explanation

    Schedule I is reserved for substances with high abuse potential, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. Schedule II substances also have high abuse potential but do have accepted medical uses.

  2. Question 2Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A community pharmacy registered with DEA to handle controlled substances must renew that registration at what interval?

    1. Every year
    2. Every 2 years
    3. Every 3 years Correct answer.
    4. Every 5 years

    Explanation

    DEA registrations are issued for a 36-month period, so a pharmacy renews its controlled substance registration every three years. Renewal must be completed before the expiration date for continued authority to handle controlled substances.

  3. Question 3Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which statement about a prescription for a Schedule II controlled substance is correct under federal law?

    1. It may be refilled without limit while the prescription is valid
    2. It may not be refilled Correct answer.
    3. It may be refilled up to five times within six months
    4. It may be refilled once if the prescriber authorizes

    Explanation

    Federal law prohibits refilling a Schedule II prescription; a new prescription is required for additional dispensing. Refills are permitted only for Schedule III, IV, and V prescriptions, subject to limits.

  4. Question 4Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under federal law, what is the maximum number of refills permitted on a prescription for a Schedule IV controlled substance?

    1. No refills
    2. Five refills Correct answer.
    3. One refill
    4. Three refills

    Explanation

    A prescription for a Schedule III, IV, or V controlled substance may be refilled up to five times, and each refill must occur within six months of the date the prescription was issued. The prescriber may authorize fewer refills.

  5. Question 5Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the Combat Methamphetamine Epidemic Act, what is the maximum daily retail amount of pseudoephedrine base that may be sold to a single purchaser?

    1. 7.5 grams
    2. 9 grams
    3. 1.8 grams
    4. 3.6 grams Correct answer.

    Explanation

    The Combat Methamphetamine Epidemic Act caps retail sales of pseudoephedrine at 3.6 grams per purchaser per calendar day. It also caps sales at 9 grams per purchaser in a 30-day period.

  6. Question 6Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A DEA Form 222 (or its electronic equivalent, CSOS) is used by a pharmacy to perform which function?

    1. Register a new pharmacy location with DEA
    2. Order Schedule I and Schedule II controlled substances Correct answer.
    3. Document the destruction of controlled substances
    4. Report the theft or loss of controlled substances

    Explanation

    DEA Form 222 is the order form used to transfer Schedule I and Schedule II controlled substances between registrants, such as a pharmacy purchasing from a distributor. It is not used for reporting losses, destruction, or registration.

  7. Question 7Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A patient asks that a prescription be dispensed in a container that is not child resistant. Under the Poison Prevention Packaging Act, the pharmacist may comply under which circumstance?

    1. Only if the prescriber authorizes it in writing
    2. If the patient requests it Correct answer.
    3. Only for drugs that are not controlled substances
    4. Only if the pharmacy posts a public notice

    Explanation

    The Poison Prevention Packaging Act requires child-resistant packaging for most oral prescription drugs but allows noncomplying packaging when the prescriber directs it or when the purchaser requests it. The patient's request alone is sufficient.

  8. Question 8Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which disclosure is permitted under the HIPAA Privacy Rule without the patient's authorization?

    1. Disclosure of the full record to the patient's employer
    2. Disclosure to the patient's health plan to pay a claim Correct answer.
    3. Disclosure to a marketing firm promoting a new product
    4. Disclosure of psychotherapy notes to a family member

    Explanation

    Disclosures for treatment, payment, and health care operations do not require patient authorization, and submitting a claim to a health plan is a payment activity. Psychotherapy notes and marketing uses generally require specific authorization.

  9. Question 9Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which statement about the controlled substance inventory a DEA-registered pharmacy must take is correct?

    1. Exact counts are required for all schedules from II through V
    2. Exact counts are required for Schedule III through V and counts may be estimated for Schedule II
    3. Counts may be estimated for all schedules if purchase records are complete
    4. Exact counts are required for Schedule II and counts may be estimated for Schedule III through V Correct answer.

    Explanation

    A biennial inventory must be taken every two years, and Schedule II substances must be counted exactly. Schedule III, IV, and V substances may be estimated unless the container holds more than 1,000 tablets or capsules.

  10. Question 10Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacy discovers that 200 oxycodone tablets are missing and finds no evidence of a break-in. Which DEA form is used to report this to the agency?

    1. DEA Form 222
    2. DEA Form 224
    3. DEA Form 41
    4. DEA Form 106 Correct answer.

    Explanation

    In-transit and significant losses of controlled substances are reported to DEA on Form 106, generally within one business day of discovery. The registrant must also notify local law enforcement when a theft is suspected.

  11. Question 11Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacist who is not the DEA registrant needs to sign a DEA Form 222 to order Schedule II drugs for the pharmacy. What is required for this to be valid?

    1. The pharmacist must obtain a separate DEA registration for the pharmacy
    2. The registrant must execute a power of attorney naming the pharmacist as agent Correct answer.
    3. The distributor may accept the pharmacist's verbal order instead
    4. The pharmacist must file DEA Form 224 before signing

    Explanation

    A registrant may authorize one or more individuals to execute Form 222 by executing a power of attorney for each person. The power of attorney must be retained with the executed order forms and made available for inspection.

  12. Question 12Federal statutes, regulations, and agency guidance affecting pharmacy practice

    In a documented emergency, a pharmacist dispenses a Schedule II controlled substance on a prescriber's oral order. Within what period must the prescriber furnish a written or electronic prescription to the pharmacy?

    1. 14 days
    2. 5 days
    3. 72 hours
    4. 7 days Correct answer.

    Explanation

    When a Schedule II drug is dispensed on an emergency oral order, the prescriber must deliver a written or electronic prescription within seven days. If it is not received, the pharmacist must notify DEA.

  13. Question 13Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under federal law, which Schedule II prescription may lawfully be transmitted to the pharmacy by fax?

    1. A prescription for a patient younger than 18 years
    2. A prescription paid for in cash by the patient
    3. A prescription for a 90-day supply written by a family physician
    4. A prescription for a patient in a long-term care facility Correct answer.

    Explanation

    Faxed Schedule II prescriptions are permitted for patients in long-term care facilities, for patients receiving hospice care, and for compounded preparations for direct administration to a patient by a practitioner. Other Schedule II prescriptions must be written or electronic.

  14. Question 14Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under HIPAA, a covered entity must act on an individual's request for access to their protected health information within how many days?

    1. 60 days
    2. 15 days
    3. 10 days
    4. 30 days Correct answer.

    Explanation

    The HIPAA Privacy Rule requires a covered entity to provide requested access within 30 days of the request, with the possibility of one 30-day extension if certain conditions are met. A reasonable, cost-based fee may be charged.

  15. Question 15Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A patient requests an accounting of disclosures of their protected health information. Which disclosure must generally be included in the accounting?

    1. Disclosures to a public health authority as required by law Correct answer.
    2. Disclosures to the patient's cardiologist for treatment
    3. Disclosures to the pharmacy for its own operations
    4. Disclosures to the health plan for payment

    Explanation

    An accounting of disclosures covers disclosures made outside of treatment, payment, and health care operations, including those required by law such as public health reporting. Disclosures for treatment, payment, and operations are excluded.

  16. Question 16Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which activity is permitted under the Prescription Drug Marketing Act?

    1. A manufacturer's representative gives samples to a prescriber Correct answer.
    2. A wholesaler sells samples to retail pharmacies
    3. A pharmacy returns dispensed samples to the manufacturer for credit
    4. A pharmacy sells samples to patients at a reduced price

    Explanation

    The Prescription Drug Marketing Act bars the sale, purchase, or trade of drug samples and prohibits their resale after dispensing. Manufacturers and their representatives may distribute samples to licensed practitioners who request them.

  17. Question 17Federal statutes, regulations, and agency guidance affecting pharmacy practice

    OBRA 1990 requires state Medicaid programs to provide which service at the point a prescription is dispensed?

    1. Reimbursement for all over-the-counter products
    2. A 90-day supply for all maintenance medications
    3. Mandatory generic substitution in every state
    4. Prospective drug utilization review before the prescription is dispensed Correct answer.

    Explanation

    OBRA 1990 established prospective and retrospective drug utilization review requirements for state Medicaid programs. Prospective review screens the prescription before dispensing for therapeutic duplication, interactions, and other problems.

  18. Question 18Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which feature is characteristic of a risk evaluation and mitigation strategy that includes elements to assure safe use?

    1. A boxed warning is added to the prescribing information
    2. Prescriber certification and patient enrollment are required before dispensing Correct answer.
    3. A Medication Guide is dispensed with each prescription
    4. A phase 4 clinical trial is required after approval

    Explanation

    Elements to assure safe use are the most restrictive REMS component and may include prescriber or dispenser certification, patient enrollment, and documentation of safe-use conditions before a drug may be dispensed. A Medication Guide alone is a less restrictive REMS element, not an element to assure safe use.

  19. Question 19Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the Combat Methamphetamine Epidemic Act, which requirement applies to a retail sale of pseudoephedrine?

    1. The purchaser must provide a DEA registration number
    2. The sale must be reported to DEA within 24 hours
    3. The purchaser must be at least 21 years old
    4. The purchaser must sign a logbook and present photo identification Correct answer.

    Explanation

    Retail sellers must maintain a written or electronic logbook recording the purchaser's signature, name, address, and date and time of sale, and must verify identity with a photo ID. Regulated products must be kept behind the counter or in a locked cabinet.

  20. Question 20Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacist receives a cash Schedule II prescription for a high dose of an opioid written by a prescriber hundreds of miles from the patient's home, and the pattern suggests misuse. Under DEA rules, the pharmacist:

    1. must resolve the red flags before dispensing Correct answer.
    2. should dispense and record only the prescriber's DEA number
    3. may dispense but must notify DEA within 24 hours
    4. must dispense any prescription valid on its face

    Explanation

    A pharmacist shares a corresponding responsibility with the prescriber to ensure a controlled substance prescription is issued for a legitimate medical purpose in the usual course of professional practice. Red flags must be resolved and documented before dispensing.

  21. Question 21Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A single DEA Form 222 may list a maximum of how many line items?

    1. 10 Correct answer.
    2. 5
    3. 15
    4. 20

    Explanation

    Each DEA Form 222 contains ten numbered lines, so no more than ten items may be ordered on one form. If more items are needed, additional forms must be executed.

  22. Question 22Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the Drug Supply Chain Security Act, how long must trading partners retain transaction information and transaction statements?

    1. 6 years Correct answer.
    2. 2 years
    3. 3 years
    4. 10 years

    Explanation

    DSCSA requires trading partners to retain transaction information and transaction statements for not less than six years after the date of the transaction. These records must be provided to FDA or authorized regulators upon request.

  23. Question 23Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which requirement applies to a 503B outsourcing facility but not to a traditional 503A compounding pharmacy?

    1. It must follow current good manufacturing practice and report serious adverse events Correct answer.
    2. It may compound only nonsterile products
    3. It must obtain a patient-specific prescription before compounding
    4. It is exempt from FDA inspection

    Explanation

    A 503B outsourcing facility must comply with current good manufacturing practice and report serious adverse events to FDA, among other requirements. Section 503A pharmacies compound only pursuant to patient-specific prescriptions or limited anticipatory orders.

  24. Question 24Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A new drug application holder learns of a serious and unexpected adverse event associated with its product. Under FDA regulations, the report must be submitted within how many calendar days?

    1. 30 calendar days
    2. 5 calendar days
    3. 10 calendar days
    4. 15 calendar days Correct answer.

    Explanation

    Applicants must report serious and unexpected adverse drug experiences to FDA within 15 calendar days of initial receipt of the information. Fatal or life-threatening unexpected events must be reported by telephone or fax within 7 calendar days.

  25. Question 25Federal statutes, regulations, and agency guidance affecting pharmacy practice

    The FDA's Pregnancy and Lactation Labeling Rule replaced which prior labeling format?

    1. The generally recognized as safe statement
    2. The pregnancy letter categories A, B, C, D, and X Correct answer.
    3. The boxed warning format
    4. The pediatric exclusivity designation

    Explanation

    The Pregnancy and Lactation Labeling Rule phased out the A, B, C, D, and X pregnancy categories in favor of narrative sections on pregnancy, lactation, and use in specific populations. The rule applies to prescription drug and biologic labeling.

  26. Question 26Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which federal statute first established a distinct class of drugs that could be dispensed only on the order of a licensed prescriber?

    1. The Kefauver-Harris Amendment of 1962
    2. The Federal Food, Drug, and Cosmetic Act of 1938
    3. The Prescription Drug Marketing Act of 1987
    4. The Durham-Humphrey Amendment of 1951 Correct answer.

    Explanation

    The Durham-Humphrey Amendment divided drugs into prescription (legend) and over-the-counter categories and limited legend drugs to dispensing on a prescriber's order. It also authorized oral prescriptions and refills for legend drugs under federal law.

  27. Question 27Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the federal Controlled Substances Act, how many times may a pharmacy refill a prescription for a Schedule II controlled substance?

    1. Up to five times, as long as all refills occur within six months
    2. Up to three times, if the prescriber authorizes refills on the original
    3. None; refilling a Schedule II prescription is prohibited Correct answer.
    4. Once, if the prescriber specifically authorizes a single refill

    Explanation

    Federal law bars refilling a Schedule II prescription, so a new prescription is needed for each dispensing. A state may add stricter rules but cannot authorize Schedule II refills.

  28. Question 28Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A prescriber authorizes refills on a Schedule IV prescription. Under federal law, the prescription may be refilled:

    1. Once only, within 90 days of the date the prescription is issued
    2. Unlimited refills for one year from the date the prescription is issued
    3. Up to five times within six months of the issue date Correct answer.
    4. Up to five times with no limit on the total time period

    Explanation

    For Schedule III and IV prescriptions, federal law permits as many as five refills, and no refill may be dispensed more than six months after the prescription was issued. Each partial refill counts toward the five-refill maximum.

  29. Question 29Federal statutes, regulations, and agency guidance affecting pharmacy practice

    How often must a DEA-registered pharmacy renew its DEA registration?

    1. Every five years
    2. Every three years Correct answer.
    3. Every two years
    4. Every year

    Explanation

    DEA registrations for pharmacies and practitioners are valid for three years and must be renewed before expiration to continue handling controlled substances. Operating on an expired registration is unlawful.

  30. Question 30Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under DEA regulations, how long must a registered pharmacy retain records of controlled substances received and dispensed?

    1. Two years Correct answer.
    2. One year
    3. Five years
    4. Three years

    Explanation

    Registrants must keep complete and accurate records of controlled substances received, sold, dispensed, or otherwise disposed of for at least two years. The records must be maintained at the registered location and be readily retrievable.

  31. Question 31Federal statutes, regulations, and agency guidance affecting pharmacy practice

    After discovering a breach of unsecured protected health information, a covered entity must notify affected individuals without unreasonable delay and no later than:

    1. 90 days after discovery
    2. 60 days after discovery Correct answer.
    3. 15 days after discovery
    4. 30 days after discovery

    Explanation

    The HIPAA Breach Notification Rule requires notice to affected individuals without unreasonable delay and in no case later than 60 calendar days after discovery of the breach. Larger breaches also trigger notice to the media and to HHS.

  32. Question 32Federal statutes, regulations, and agency guidance affecting pharmacy practice

    The Kefauver-Harris Amendment of 1962 added which requirement to the new drug approval process?

    1. A risk evaluation and mitigation strategy for the drug
    2. A demonstration of bioequivalence to an approved reference product
    3. A certification that the drug is not covered by any patent
    4. Substantial evidence of effectiveness in addition to safety Correct answer.

    Explanation

    Kefauver-Harris required that a new drug application demonstrate substantial evidence of effectiveness as well as safety. It also shifted responsibility for reviewing investigational drug use to FDA and strengthened informed consent requirements.

  33. Question 33Federal statutes, regulations, and agency guidance affecting pharmacy practice

    The labeling of a prescription drug product must bear which statement to distinguish it from an over-the-counter drug?

    1. Rx only Correct answer.
    2. Warning: may cause drowsiness
    3. For external use only
    4. Keep out of reach of children

    Explanation

    FDA regulations require prescription drug labeling to bear the symbol "Rx only," which replaced the older legend statement. The other statements are cautionary labeling elements that may appear on certain products but do not designate prescription status.

  34. Question 34Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacist sends a patient's medication list to the patient's cardiologist to coordinate care. Which statement about the HIPAA minimum necessary standard is correct?

    1. The pharmacist may send only the single medication that prompted the referral
    2. The pharmacist must obtain the patient's written authorization before sending the list
    3. The pharmacist must limit the disclosure to the minimum necessary for the cardiologist's payment activities
    4. The minimum necessary standard does not apply to disclosures to a provider for treatment Correct answer.

    Explanation

    Minimum necessary governs most uses and disclosures of protected health information, but it expressly does not apply to disclosures to a health care provider for treatment or to disclosures to the individual. Sending the full medication list for treatment purposes is therefore permissible.

  35. Question 35Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which of the following products is exempt from the child-resistant packaging requirements of the Poison Prevention Packaging Act?

    1. Amoxicillin oral suspension
    2. Immediate-release oxycodone tablets
    3. Pediatric acetaminophen oral suspension
    4. Sublingual nitroglycerin tablets Correct answer.

    Explanation

    FDA regulations exempt certain products from child-resistant packaging, including sublingual dosage forms of nitroglycerin and sublingual or chewable isosorbide dinitrate. Most oral prescription products, including opioids and antibiotic suspensions, must be dispensed in child-resistant containers.

  36. Question 36Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the Drug Supply Chain Security Act, after a trading partner determines that a product in its possession is illegitimate, the partner must notify FDA and other affected trading partners in the supply chain within:

    1. 3 business days
    2. 10 calendar days
    3. 24 hours Correct answer.
    4. 30 calendar days

    Explanation

    The DSCSA requires a trading partner that determines a product is illegitimate to notify FDA and immediate trading partners as soon as possible and no later than 24 hours after the determination. Related suspect product investigations use a separate, longer timeline.

  37. Question 37Federal statutes, regulations, and agency guidance affecting pharmacy practice

    An applicant submitting an abbreviated new drug application must establish which of the following?

    1. Clinical superiority over the reference listed drug
    2. Full safety and efficacy data from new clinical trials sponsored by the applicant
    3. Bioequivalence to the reference listed drug Correct answer.
    4. That the active ingredient is a new chemical entity

    Explanation

    An ANDA relies on FDA's prior findings of safety and effectiveness for the reference listed drug, so the applicant must instead show bioequivalence and adequate chemistry, manufacturing, and labeling. It also must address patents covering the reference drug.

  38. Question 38Federal statutes, regulations, and agency guidance affecting pharmacy practice

    FDA assigns a recall to Class I when:

    1. Use of the product may cause serious adverse health consequences or death Correct answer.
    2. The product has a labeling defect that could mislead prescribers about dosing
    3. The product is unlikely to cause any adverse health consequences
    4. The product causes only temporary or medically reversible harm

    Explanation

    Class I is reserved for situations in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II covers temporary or reversible harm, and Class III covers violations unlikely to cause harm.

  39. Question 39Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A drug granted pediatric exclusivity receives an additional period of market exclusivity of:

    1. Six months Correct answer.
    2. Two years
    3. One year
    4. Three months

    Explanation

    When a sponsor completes requested pediatric studies, FDA may attach an additional six months of exclusivity to existing patent or nonpatent exclusivity. The six months is added to the end of the existing protection rather than running concurrently.

  40. Question 40Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A DEA-registered pharmacy needs to destroy outdated controlled substances on site. Which DEA form documents this destruction?

    1. DEA Form 106
    2. DEA Form 224
    3. DEA Form 41 Correct answer.
    4. DEA Form 222

    Explanation

    DEA Form 41 is the record of destruction used to document controlled substances destroyed by a registrant. Form 106 reports theft or significant loss, Form 222 orders Schedule I and II substances, and Form 224 is the application for registration.

  41. Question 41Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A prescriber issues a Schedule II prescription for a terminally ill patient for 120 tablets and notes that the patient may need the quantity in installments. Under DEA rules, the remaining portions must be dispensed no later than:

    1. 90 days from the date of issue
    2. Six months from the date of issue
    3. 30 days from the date of issue
    4. 60 days from the date of issue Correct answer.

    Explanation

    Partial filling of a Schedule II prescription is permitted for patients in a long-term care facility or with a terminal illness, provided all remaining portions are dispensed within 60 days of the date the prescription was written. Otherwise, a partial fill for insufficient supply must be completed within 72 hours.

  42. Question 42Federal statutes, regulations, and agency guidance affecting pharmacy practice

    The federal Anti-Kickback Statute prohibits:

    1. Knowingly offering remuneration to induce referrals of federally payable items Correct answer.
    2. A wholesaler giving a pharmacy a volume discount that is disclosed in the purchase agreement
    3. Dispensing a drug that does not appear on a payer's formulary because the prescriber requested it
    4. Providing a patient, on request, a copy of the patient's own prescription records

    Explanation

    The statute makes it a criminal offense to knowingly and willfully offer, pay, solicit, or receive remuneration to induce referrals for items or services reimbursable by a federal health care program. Discounts are analyzed under the statute and its safe harbors, and properly structured bona fide discounts may be protected.

  43. Question 43Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacy hires an outside vendor to perform billing services that require access to protected health information. What must the pharmacy do before sharing the information?

    1. Execute a written business associate agreement with the vendor Correct answer.
    2. Post a notice describing the arrangement on the pharmacy's public website
    3. Notify the HHS Office for Civil Rights within 30 days of the arrangement
    4. Obtain a written authorization from each affected patient

    Explanation

    A covered entity may disclose protected health information to a business associate only after obtaining satisfactory written assurances that the associate will safeguard the information. That contract, the business associate agreement, must address permitted uses, safeguards, and breach reporting.

  44. Question 44Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacy corporation opens a second location in the same state. Regarding DEA registration, the corporation must:

    1. Obtain a modified registration from the state board of pharmacy only
    2. Notify DEA within 30 days and keep operating under the original registration number
    3. Use the existing registration at the new location until it comes up for renewal
    4. Obtain a separate DEA registration for each principal place of business Correct answer.

    Explanation

    A separate DEA registration is required for each principal place of business or professional practice where controlled substances are handled. A state pharmacy license does not substitute for federal registration at the new site.

  45. Question 45Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A pharmacy sells a Schedule V cough preparation without a prescription. Which federal requirement applies?

    1. The sale must be recorded on a DEA Form 222
    2. The purchaser must be at least 18 and the sale must be recorded Correct answer.
    3. The product must be kept behind the counter, with no record required
    4. The sale may not occur without a prescriber's oral order

    Explanation

    Dispensing a Schedule V controlled substance without a prescription requires that the purchaser be at least 18 years old and present appropriate identification, and the pharmacist must keep a written or electronic record of the sale. The record identifies the purchaser, the product, the quantity, and the date.

  46. Question 46Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A 2023 DEA final rule permits which of the following for electronic prescriptions for controlled substances?

    1. Use of a shared password by pharmacists at the same store
    2. Transmission of a Schedule II prescription directly to the patient by email
    3. Transfer of an unfilled electronic prescription to another pharmacy Correct answer.
    4. Refilling a Schedule II electronic prescription up to five times

    Explanation

    DEA now permits a pharmacy to transfer an unfilled electronic prescription for a Schedule II through V controlled substance to another pharmacy for initial filling, subject to documentation and pharmacy-to-pharmacy communication requirements. Refills of Schedule II prescriptions and shared credentials remain prohibited.

  47. Question 47Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Which statement about 180-day exclusivity under the Hatch-Waxman Amendments is correct?

    1. It is granted automatically to every applicant that files a Paragraph IV certification
    2. It applies only to biologics licensed under a biologics license application
    3. It lasts five years and blocks every subsequent ANDA from being approved
    4. It is awarded to the first ANDA applicant that files a Paragraph IV certification Correct answer.

    Explanation

    The first applicant to submit a substantially complete ANDA containing a Paragraph IV certification earns 180 days of exclusivity against later Paragraph IV filers. Certain later applicants, such as one that obtains a court decision of invalidity or noninfringement, may share in that exclusivity.

  48. Question 48Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the Ryan Haight Act, a practitioner generally may prescribe a controlled substance via telemedicine only if:

    1. The practitioner has conducted an in-person evaluation or meets an exception Correct answer.
    2. The prescription is transmitted by fax rather than electronically
    3. The patient signs a written waiver of the in-person examination requirement
    4. The prescription is limited to a 30-day supply of the controlled substance

    Explanation

    The Ryan Haight Act requires at least one in-person medical evaluation before a practitioner may prescribe a controlled substance by means of the internet, unless a specified exception applies, such as treatment in a DEA-registered facility or an applicable public health emergency flexibility. The required evaluation must occur before the telemedicine prescribing.

  49. Question 49Federal statutes, regulations, and agency guidance affecting pharmacy practice

    A traditional 503A compounding pharmacy generally may not compound a drug that is essentially a copy of a commercially available product unless:

    1. The compounded preparation is priced lower than the commercial product
    2. The commercial product is on FDA's drug shortage list Correct answer.
    3. The patient's prescriber signs a waiver of the prohibition
    4. The pharmacy compounds the preparation fewer than ten times per month

    Explanation

    Section 503A excludes from the exempt compounding definition drugs that are essentially copies of a commercially available product, unless the prescriber determines a change produces a significant difference for the patient or the commercial product appears on FDA's drug shortage list. Price and volume do not create an exception.

  50. Question 50Federal statutes, regulations, and agency guidance affecting pharmacy practice

    Under the HIPAA Privacy Rule, which statement about psychotherapy notes is correct?

    1. They are part of the designated record set and must be produced on an access request
    2. They may be disclosed to a health plan for care coordination without authorization
    3. They require a specific patient authorization for most disclosures Correct answer.
    4. They may be disclosed for payment purposes without authorization

    Explanation

    Psychotherapy notes receive heightened protection and generally may be used or disclosed only with a specific authorization, apart from narrow exceptions such as the originator's own treatment use and certain oversight functions. They are also excluded from the designated record set for access purposes.

  51. Question 51Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Which entity is primarily responsible for enforcing state pharmacy laws and regulating the practice of pharmacy within a state?

    1. The Drug Enforcement Administration
    2. The state board of pharmacy Correct answer.
    3. The U.S. Food and Drug Administration
    4. The state medical board

    Explanation

    State boards of pharmacy are administrative agencies created by the state pharmacy practice act. They license pharmacists and pharmacies and enforce state pharmacy law. The FDA regulates drug approval and labeling, while the DEA enforces federal controlled substance laws.

  52. Question 52Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State boards of pharmacy typically require pharmacists to complete continuing education as a condition of:

    1. License renewal Correct answer.
    2. Obtaining a DEA registration
    3. Pharmacy accreditation
    4. Initial licensure only

    Explanation

    Continuing education is a condition of license renewal in essentially every state. Initial licensure requires graduation, internship hours, and examinations. CE is not tied to DEA registration or pharmacy accreditation.

  53. Question 53Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under most state pharmacy practice acts, a pharmacy intern must:

    1. Hold a current technician certification
    2. Work without pharmacist supervision
    3. Practice only in a hospital setting
    4. Be registered with the board Correct answer.

    Explanation

    Interns must be registered with the board and practice under pharmacist supervision. Registration confirms enrollment in or graduation from an accredited pharmacy program. Interns are not required to hold technician certification.

  54. Question 54Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State law generally requires that a prescription for a non-controlled medication include which element?

    1. Prescriber's name and signature Correct answer.
    2. Patient's social security number
    3. Prescriber's DEA number
    4. Insurance policy number

    Explanation

    A valid prescription must identify the prescriber and include a signature. DEA numbers are required only for controlled substances. Social security and insurance numbers are not legal requirements for prescription validity.

  55. Question 55Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under state pharmacy rules, patient counseling is typically:

    1. Optional and never documented
    2. Required only for controlled substances
    3. An offer required for new prescriptions Correct answer.
    4. Prohibited unless the patient requests it

    Explanation

    State rules generally require pharmacists to offer counseling on each new prescription. The offer and any refusal may need documentation. Counseling is not limited to controlled substances.

  56. Question 56Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Which item is generally required on a prescription label by state law?

    1. Patient's diagnosis
    2. Pharmacist's home address
    3. Pharmacy name and address Correct answer.
    4. Prescriber's DEA registration number

    Explanation

    Labels must identify the pharmacy and provide patient-specific directions. Prescriber DEA numbers and patient diagnoses are not label requirements. The pharmacist's home address is never required.

  57. Question 57Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State boards of pharmacy typically require prescription records to be retained for:

    1. Six months from the dispensing date
    2. Indefinitely, with no destruction
    3. A period set by state law Correct answer.
    4. Thirty days from the dispensing date

    Explanation

    Retention periods are set by state statute or board rule and commonly range from two to five years. Federal law separately requires two-year retention for controlled substance records. Records cannot be destroyed immediately or kept indefinitely without a legal basis.

  58. Question 58Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Pharmacists' authority to administer immunizations is generally established by:

    1. State statute or board rule Correct answer.
    2. The Drug Enforcement Administration
    3. The U.S. Food and Drug Administration
    4. The Joint Commission on accreditation

    Explanation

    Immunization authority is granted by state statute or board rule, often with training and CPR requirements. The FDA and DEA do not authorize pharmacist immunization practice. The Joint Commission is an accrediting body, not a licensing authority.

  59. Question 59Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A patient asks to transfer a prescription for a Schedule III medication to another pharmacy. Under state and federal rules, the transfer:

    1. Requires a new prescription in all cases
    2. May be transferred once with documentation Correct answer.
    3. May be repeated unlimited times verbally
    4. Is forbidden for Schedule III

    Explanation

    Federal rules permit a controlled substance prescription to be transferred once between pharmacies for refill purposes. The transfer must be documented and communicated between pharmacists. State rules may impose additional conditions, but unlimited verbal transfers are not allowed.

  60. Question 60Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacist dispensing a controlled substance generally must query the state prescription drug monitoring program:

    1. Never, because PDMP participation is voluntary
    2. As required by state law Correct answer.
    3. Only when the patient requests a refill
    4. Only for Schedule II controlled substances

    Explanation

    Many states mandate PDMP queries before dispensing opioids or other controlled substances. Requirements vary by state and may include suspicion-based checks. PDMP participation is not voluntary where mandated.

  61. Question 61Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under a collaborative practice agreement, a pharmacist may:

    1. Modify therapy under agreed protocols Correct answer.
    2. Diagnose independently without a physician
    3. Practice without a state license
    4. Prescribe any controlled substance

    Explanation

    A collaborative practice agreement lets a pharmacist manage drug therapy under protocols developed with a prescriber. It does not authorize independent diagnosis or prescribing outside the protocol. A state license is always required.

  62. Question 62Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State laws permitting pharmacists to dispense emergency contraception without a prescription typically require:

    1. A prescription from an obstetrician
    2. Board-approved protocol Correct answer.
    3. Prior insurance authorization
    4. A valid DEA registration number

    Explanation

    States that allow pharmacist dispensing of emergency contraception typically require a board-approved protocol, counseling, and documentation. Emergency contraception is not a controlled substance, so no DEA number is needed. A prescription is not required under these protocols.

  63. Question 63Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Unless the prescriber indicates 'dispense as written,' state law generally:

    1. Require written patient consent only
    2. Allow generic substitution Correct answer.
    3. Forbid substitution in all cases
    4. Require the brand name to be dispensed

    Explanation

    State substitution laws allow or require dispensing a therapeutically equivalent generic unless the prescriber writes 'dispense as written.' Patient notification or consent requirements vary. Brand-only dispensing is not the default.

  64. Question 64Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under state law, an electronic prescription for a controlled substance must generally:

    1. Meet EPCS authentication rules Correct answer.
    2. Be printed and hand-signed
    3. Be given verbally by phone
    4. Be transmitted by fax to the pharmacy

    Explanation

    Electronic prescriptions for controlled substances must satisfy DEA electronic prescribing rules and any state requirements. Authentication and system certification are key. Fax and verbal orders are not the equivalent of EPCS.

  65. Question 65Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    When a pharmacy permanently closes, state board rules typically require the pharmacy to:

    1. Destroy all records immediately Correct answer.
    2. Sell prescription records to another pharmacy
    3. Notify the board and preserve records
    4. Continue dispensing for 30 days

    Explanation

    Boards require notice of closure and a plan for prescription records. Records must be preserved or transferred according to board rules. Selling records or destroying them immediately is not permitted.

  66. Question 66Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacy that compounds sterile preparations must generally comply with:

    1. No external standards apply
    2. Only state statutes and board rules
    3. USP <797> and state rules Correct answer.
    4. Only federal Food and Drug Administration rules

    Explanation

    Many state boards adopt USP <797> for sterile compounding and USP <795> for nonsterile compounding. Compliance with these standards is enforced through board rules. Federal and state law both apply, but 'no standards' is incorrect.

  67. Question 67Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State board rules regarding medication errors typically:

    1. Forbid documentation of errors
    2. Encourage internal quality programs Correct answer.
    3. Require reporting only to the DEA
    4. Require public disclosure of every error

    Explanation

    State rules on medication errors often focus on quality improvement and may require internal reporting. Some states mandate reporting to the board for certain errors. Public disclosure of every error and DEA-only reporting are not typical.

  68. Question 68Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Before dispensing a prescription, a pharmacist's corresponding responsibility includes:

    1. Resolve red flags about prescription legitimacy Correct answer.
    2. Ignoring unusual patterns
    3. Checking the patient's credit
    4. Contacting the police for all controlled substances

    Explanation

    Pharmacists share a corresponding responsibility to ensure controlled substance prescriptions have a legitimate medical purpose. Red flags such as unusual patterns must be resolved before dispensing. Contacting police for every controlled substance is not required.

  69. Question 69Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacist licensed in one state who wishes to practice in another state generally must:

    1. Take no action before practicing
    2. Obtain licensure by endorsement Correct answer.
    3. Only pay a reciprocity fee
    4. Automatically practice under the first license

    Explanation

    A pharmacist must hold a license in each state where they practice. Licensure by reciprocity or endorsement is the usual route. Paying a fee alone or practicing automatically is insufficient.

  70. Question 70Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    The state board of pharmacy's disciplinary authority typically includes:

    1. Impose criminal imprisonment
    2. Award civil damages to patients
    3. Set federal reimbursement rates
    4. Restrict or revoke licenses Correct answer.

    Explanation

    Boards impose administrative sanctions such as suspension, revocation, restriction, and fines. They do not imprison individuals or award civil damages. Reimbursement rates are set by payers, not boards.

  71. Question 71Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    If a state schedules a substance more restrictively than federal law, the pharmacist should:

    1. Follow federal schedule only
    2. Dispense without a prescription
    3. Follow the state schedule Correct answer.
    4. Ignore state law entirely

    Explanation

    When state and federal schedules differ, the more restrictive rule controls. A state may place a substance in a stricter schedule. Federal registration does not override stricter state law.

  72. Question 72Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A prescription presented after the state's allowed time limit for filling has expired is generally:

    1. Still valid indefinitely
    2. Valid only for controlled substances
    3. Invalid without a new prescription Correct answer.
    4. Valid if the patient pays cash

    Explanation

    States set time limits for filling prescriptions. After the limit, the prescription is no longer valid and a new prescription is needed. Cash payment does not revive an expired prescription.

  73. Question 73Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Remote pharmacy practice and telepharmacy are typically permitted:

    1. Without any board authorization or notification
    2. Under specific board rules Correct answer.
    3. Only for controlled substance prescriptions
    4. Only in hospital pharmacy settings

    Explanation

    Telepharmacy is authorized by board rules that address technology, supervision, and counseling. It is not permitted without authorization. It is not limited to hospitals or controlled substances.

  74. Question 74Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacist's DEA registration:

    1. Replaces the state license
    2. Is issued by the state board
    3. Allows practice without a state license
    4. Does not replace a state license Correct answer.

    Explanation

    DEA registration is a federal controlled substance registration. It does not replace the state license required to practice pharmacy. State boards issue pharmacy licenses, not DEA registrations.

  75. Question 75Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    For a nonsterile compounded preparation, the beyond-use date is generally determined by:

    1. A fixed one-year date for all compounds
    2. The prescriber's written preference only
    3. The manufacturer's expiration date
    4. USP <795> criteria Correct answer.

    Explanation

    The beyond-use date for nonsterile compounds is determined using USP <795> criteria, as adopted by the board. Manufacturer expiration dates apply to manufactured products. A single fixed date for all compounds is not appropriate.

  76. Question 76Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under federal law as adopted by state boards of pharmacy, how many refills are permitted on a prescription for a Schedule IV controlled substance, and within what period?

    1. Two refills within one year of the issue date
    2. Five refills within six months of the issue date Correct answer.
    3. No refills are permitted for any controlled substance
    4. Unlimited refills within one year with prescriber authorization

    Explanation

    The federal Controlled Substances Act permits up to five refills on a Schedule III, IV, or V prescription, and all refills must be dispensed within six months of the date the prescription was issued. State boards adopt this limit through their own controlled substance rules.

  77. Question 77Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A prescriber telephones an emergency oral prescription for a Schedule II controlled substance. Under federal rules enforced by state boards, the prescriber must furnish a written prescription within:

    1. 7 days Correct answer.
    2. 24 hours
    3. 30 days
    4. 72 hours

    Explanation

    An emergency oral order for a Schedule II drug is allowed only in a genuine emergency, and the prescriber must deliver a written prescription to the dispensing pharmacy within seven days. If the written order does not arrive, the pharmacist must report the matter to DEA.

  78. Question 78Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacist has a professional or clinical concern about a prescription presented at the counter. Under state board rules, the pharmacist may generally:

    1. Require the patient to sign a liability waiver before dispensing
    2. Decline to fill the prescription after notifying the prescriber Correct answer.
    3. Dispense the drug but omit patient counseling
    4. Reduce the dose without contacting the prescriber

    Explanation

    Pharmacists exercise independent professional judgment in filling prescriptions and may refuse to dispense when a prescription appears invalid or unsafe, but they should document the concern and inform the prescriber. A pharmacist may not unilaterally alter a prescription.

  79. Question 79Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State board of pharmacy rules generally require a pharmacist to offer counseling to:

    1. Only patients enrolled in Medicaid or other public programs
    2. Only new prescriptions for controlled substances
    3. Only patients who submit a written request
    4. Each patient receiving a new prescription, unless declined Correct answer.

    Explanation

    Boards require an offer to counsel with each new prescription, with the patient free to decline. The offer must be documented in many states, and counseling cannot be limited to select payers or drug classes.

  80. Question 80Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    To renew a pharmacist license, state boards of pharmacy generally require:

    1. Completion of continuing education hours during each renewal period Correct answer.
    2. A passing score on a jurisprudence examination at each annual renewal
    3. Ongoing sponsorship by a hospital pharmacy
    4. Re-examination every renewal cycle

    Explanation

    Continuing education is the standard mechanism boards use to verify maintained competence at renewal, typically with a specified number of hours including law and patient-safety topics. Re-examination and institutional sponsorship are not routine renewal conditions.

  81. Question 81Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacy discovers that a quantity of oxycodone tablets is missing during a count. Under state and federal requirements, the pharmacy must generally:

    1. Report the significant loss to the board and to DEA in writing Correct answer.
    2. Report the loss only if it exceeds one full bottle
    3. Replace the missing stock from the next regular shipment without any documentation
    4. Wait until the biennial inventory to record the discrepancy

    Explanation

    Significant losses or thefts of controlled substances must be reported to DEA and, in most states, to the board of pharmacy, with supporting documentation retained. The pharmacy should also maintain internal records of the discrepancy and any investigation.

  82. Question 82Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A registered pharmacy must take a complete inventory of all controlled substances on hand:

    1. Only when the pharmacist-in-charge changes or leaves the practice
    2. Only when requested by a DEA investigator
    3. Every two years and whenever a new DEA registration is obtained Correct answer.
    4. Every month on a fixed calendar date

    Explanation

    Federal regulations require a biennial inventory, meaning every two years, plus an initial inventory when a registrant first obtains a DEA registration. Many states also require an inventory at a change of pharmacist-in-charge.

  83. Question 83Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Prescription medications that a patient returns to a community pharmacy after they have been dispensed:

    1. May not be dispensed to another patient Correct answer.
    2. May be returned to the wholesaler for credit
    3. May be restocked if the original packaging is intact
    4. May be donated to a charitable clinic for redistribution

    Explanation

    Once a medication leaves the pharmacy, the pharmacy cannot verify its storage conditions or integrity, so it may not be returned to stock for dispensing to another patient. Disposal must follow board rules and environmental requirements.

  84. Question 84Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A patient presents an empty bottle of a non-controlled antihypertensive medication and cannot reach the prescriber. Many state boards of pharmacy allow the pharmacist to:

    1. Substitute a different antihypertensive from the same class
    2. Refuse to supply any medication under any circumstances
    3. Provide a limited emergency supply and notify the prescriber Correct answer.
    4. Dispense a full 90-day supply without prescriber authorization

    Explanation

    Emergency-supply provisions allow a pharmacist to dispense a limited quantity of a non-controlled maintenance medication to prevent an interruption in therapy. The pharmacist must document the action and notify the prescriber promptly.

  85. Question 85Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Most state boards of pharmacy authorize pharmacists to dispense naloxone:

    1. Only after a physician has examined the patient in person
    2. Only to patients with a cancer diagnosis
    3. Under a standing order or protocol Correct answer.
    4. Only in hospital pharmacy settings

    Explanation

    States have expanded naloxone access through standing orders, protocols, or direct pharmacist authority so that the antidote can be provided without a patient-specific prescription. Requirements for training and documentation vary by state.

  86. Question 86Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    When state law permits generic substitution for a brand-name prescription that does not indicate dispense as written, the pharmacist must generally:

    1. Substitute only when the prescriber writes substitution permitted on the face of the prescription
    2. Notify the patient of the substitution and record it Correct answer.
    3. Substitute only with a product made by the same manufacturer
    4. Always substitute to the lowest-cost product available in the pharmacy

    Explanation

    Generic substitution statutes typically require the pharmacist to inform the patient of the substitution and to keep a record identifying the product dispensed. Some states also require prescriber notification, and a few require patient consent.

  87. Question 87Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A prescription for a non-controlled drug written by a physician licensed in a neighboring state is presented. Under most state rules, the pharmacist may:

    1. Never fill it because the prescriber is not licensed in this state
    2. Fill it only after the prescriber obtains a license in this state
    3. Fill it if the prescription is valid in the prescriber's state Correct answer.
    4. Fill it only if the patient resides in the prescriber's state

    Explanation

    Pharmacists may generally honor prescriptions from out-of-state practitioners as long as the prescription is valid where issued and the pharmacist can verify the prescriber. Additional requirements may apply to controlled substances.

  88. Question 88Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Which situation most clearly fails the requirement for a valid prescriber-patient relationship?

    1. A physician prescribes after a telehealth visit with documented history
    2. A prescriber renews a maintenance medication after an office visit
    3. A covering physician prescribes after reviewing the patient's chart
    4. A controlled substance is prescribed for a person never evaluated Correct answer.

    Explanation

    Valid prescribing requires an evaluation sufficient to establish a professional relationship, whether in person or through an acceptable telehealth encounter. Prescribing without any evaluation of the patient is the classic indicator of an invalid prescription.

  89. Question 89Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under state board rules, a certified pharmacy technician working under pharmacist supervision may generally:

    1. Perform the final verification of a filled prescription
    2. Count and label medications for pharmacist verification Correct answer.
    3. Counsel a patient on inhaler technique
    4. Administer an intramuscular injection

    Explanation

    Technicians may perform supportive tasks such as counting, labeling, and data entry, subject to pharmacist verification. Clinical functions involving professional judgment remain reserved to the pharmacist.

  90. Question 90Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    The pharmacist-in-charge of a community pharmacy is generally responsible for:

    1. Overall legal compliance and day-to-day operations Correct answer.
    2. Only the annual operating budget
    3. Only controlled substance ordering
    4. Only the scheduling and payroll of pharmacy employees

    Explanation

    The pharmacist-in-charge holds the board-facing responsibility for ensuring that the pharmacy operates in compliance with statutes and board rules. That includes recordkeeping, staffing, security, and quality-related obligations.

  91. Question 91Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    When a community pharmacy is sold to a new owner, state board rules generally require the new owner to:

    1. Obtain a DEA registration only if controlled substances are stocked
    2. Notify the board and obtain a new or amended license Correct answer.
    3. Notify the board only at the next license renewal cycle
    4. Continue operating under the prior owner's license indefinitely

    Explanation

    A change of ownership requires board notification and a new or amended pharmacy license reflecting the new ownership, along with a new DEA registration in the owner's name. Operating without the updated credentials is unlicensed practice.

  92. Question 92Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    Under federal precursor rules adopted by the states, a pharmacy selling pseudoephedrine products must generally:

    1. Sell them only with a prescription in every state
    2. Place them on open shelves for customer self-selection
    3. Keep them behind the counter and require photo ID Correct answer.
    4. Sell unlimited quantities to adult purchasers

    Explanation

    Combat Methamphetamine Epidemic Act requirements place scheduled listed chemicals behind the counter, require photographic identification of purchasers, and require a written or electronic logbook with daily and monthly quantity limits.

  93. Question 93Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State board rules generally require a pharmacy to:

    1. Display the pharmacy license conspicuously Correct answer.
    2. Post licenses only on the corporate website
    3. Display the license only during inspections
    4. Keep licenses in a locked file cabinet

    Explanation

    Licensure must be visible to the public so patients can confirm that the pharmacy and its personnel are authorized to practice. Many boards also require individual pharmacist licenses to be displayed.

  94. Question 94Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A board of pharmacy inspector arrives at a pharmacy during business hours. The pharmacy must generally:

    1. Refuse entry without a search warrant
    2. Allow inspection of the front store only
    3. Require 24-hour advance notice before entry
    4. Permit inspection of the pharmacy and its records Correct answer.

    Explanation

    Licensure constitutes consent to board inspection, and inspectors may examine the prescription department, records, and inventory without prior notice. Obstructing an inspection is itself a ground for discipline.

  95. Question 95Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A patient asks the pharmacist for a partial fill of a Schedule II prescription because the pharmacy cannot supply the full quantity. Under federal rules applied in the states, the pharmacist may:

    1. Partially fill only after the patient signs a waiver form
    2. Partially fill and supply the remainder within 30 days Correct answer.
    3. Partially fill and supply the remainder at any time within six months
    4. Not partially fill any Schedule II prescription under any circumstances

    Explanation

    Federal rules allow a partial fill of a Schedule II prescription when the pharmacist cannot supply the full quantity, with the remainder supplied within 72 hours or, if not, after prescriber notification, within 30 days of the date written. Separate rules allow partial fills for long-term care residents and terminally ill patients.

  96. Question 96Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    State board rules generally prohibit a pharmacist from:

    1. Dispense a controlled substance to themselves outside an emergency Correct answer.
    2. Fill a prescription for a coworker's spouse
    3. Sell nonprescription items to family members
    4. Fill a prescription written by a physician who is a personal friend of the pharmacist

    Explanation

    Self-dispensing of controlled substances outside a genuine emergency is prohibited because the pharmacist cannot exercise independent professional judgment. Many states extend similar limits to family members and impose documentation duties when an emergency exception applies.

  97. Question 97Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacy compounds a non-patient-specific batch of a sterile preparation intended for use by a local clinic. Under state board rules, this activity generally:

    1. Is prohibited in every state
    2. Requires sterile compounding standards and possibly a special permit Correct answer.
    3. Requires only a prescription from the clinic's medical director
    4. Is permitted without additional authorization because compounding is a pharmacy practice

    Explanation

    Producing sterile preparations without a patient-specific prescription implicates office-use compounding rules, which often require additional board authorization and full compliance with sterile compounding standards. State restrictions on office-use compounding vary and should be verified.

  98. Question 98Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A pharmacy that handles hazardous drugs must generally:

    1. Store them at room temperature in the general dispensing area
    2. Restrict their use to hospital inpatients
    3. Follow containment and personnel-protection standards Correct answer.
    4. Prepare them only by certified technicians

    Explanation

    Standards adopted or referenced by boards require engineering controls, safe work practices, and personal protective equipment for hazardous drug handling. Containment applies from receipt through disposal, not only during sterile compounding.

  99. Question 99Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    A manufacturer issues a Class I recall of a product stocked by the pharmacy. The pharmacist should generally:

    1. Return the drug to the shelf after checking lot numbers
    2. Discard the drug without documentation
    3. Quarantine the affected stock and notify patients who received it Correct answer.
    4. Continue dispensing until the current stock is exhausted

    Explanation

    Recall handling requires immediate removal of affected stock from dispensing areas, documentation of quantities returned or destroyed, and patient notification when the recall involves a serious hazard. Class I recalls involve a reasonable probability of serious adverse effects.

  100. Question 100Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

    To order Schedule II controlled substances for a pharmacy, the responsible pharmacist generally submits:

    1. A state board purchase order
    2. A wholesaler invoice only
    3. A DEA Form 41 for each order placed
    4. A DEA Form 222 or an approved electronic equivalent Correct answer.

    Explanation

    Schedule II acquisitions require the DEA Form 222 or an approved electronic ordering system, and the executed forms must be retained as records. DEA Form 41 is used to document destruction of controlled substances.

  101. Question 101Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A substance has a currently accepted medical use in treatment in the United States and a high potential for abuse that may lead to severe psychological or physical dependence. Into which schedule does the Controlled Substances Act place it?

    1. Schedule I
    2. Schedule III
    3. Schedule IV
    4. Schedule II Correct answer.

    Explanation

    Schedule II covers substances with a currently accepted medical use but a high abuse potential that may lead to severe psychological or physical dependence. Schedule I drugs have no accepted medical use, and Schedules III through V carry progressively lower abuse potential.

  102. Question 102Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A prescriber writes a prescription for hydromorphone 4 mg tablets. How many refills may the prescriber authorize on the face of the prescription?

    1. Five
    2. One
    3. None Correct answer.
    4. Two

    Explanation

    Federal law prohibits refilling a Schedule II prescription, so each dispensing requires a new prescription from the prescriber. Limited partial fills are allowed in specific circumstances, but the prescription itself cannot authorize a refill.

  103. Question 103Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A prescriber authorizes the maximum number of refills on a prescription for a Schedule IV drug. What is the federal limit?

    1. Unlimited refills within 1 year of the issue date
    2. Five refills within 2 years of the issue date
    3. No refills, and it must be dispensed within 6 months of the issue date
    4. Five refills within 6 months Correct answer.

    Explanation

    Prescriptions for Schedule III through V drugs may be refilled up to five times, and each refill must be dispensed within six months of the date the prescription was issued. After that period a new prescription is required.

  104. Question 104Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    In an emergency, a prescriber telephones an oral order for a Schedule II drug to a pharmacy. Within what period must the prescriber furnish a written or electronic prescription?

    1. 24 hours
    2. 72 hours
    3. 14 days
    4. 7 days Correct answer.

    Explanation

    For an emergency oral Schedule II order, the pharmacist may dispense the drug but must receive a written or electronic prescription within seven days. The quantity dispensed is limited to the amount needed to treat the patient during the emergency period.

  105. Question 105Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    What is the maximum number of different items that may be listed on a single DEA Form 222?

    1. 20
    2. No limit
    3. 10 Correct answer.
    4. 5

    Explanation

    A single DEA Form 222 may contain no more than ten line items. If additional items are needed, separate forms must be completed, each with its own form number.

  106. Question 106Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Federal DEA regulations require that controlled substance records be kept for at least how long?

    1. 3 years
    2. 2 years Correct answer.
    3. 10 years
    4. 5 years

    Explanation

    DEA regulations require that inventories, prescriptions, and order forms for controlled substances be kept for at least two years and be available for inspection. Some states impose a longer period, and the longer requirement controls.

  107. Question 107Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A DEA-registered pharmacy must take a new complete inventory of all controlled substances on hand how often?

    1. Every 2 years Correct answer.
    2. Every 6 months
    3. Every 3 years
    4. Every year

    Explanation

    Each registrant must take a complete and accurate inventory of all controlled substances on hand every two years. The inventory becomes part of the records that must be maintained and made available for inspection.

  108. Question 108Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A DEA registration for a pharmacy remains valid for what period before renewal is required?

    1. 5 years
    2. 3 years Correct answer.
    3. 1 year
    4. 2 years

    Explanation

    DEA registrations for pharmacies and practitioners are valid for three years, after which the registrant must renew with DEA. A registration may be renewed for additional three-year periods.

  109. Question 109Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A pharmacist discovers that 200 tablets of hydrocodone/acetaminophen are missing and believes they were stolen. What must the registrant do?

    1. Report the loss at the next regularly scheduled biennial inventory
    2. Nothing, as long as the loss is under 1,000 dosage units and is documented
    3. File DEA Form 41 with the local field office within 60 days of discovery
    4. Notify DEA in writing within one business day Correct answer.

    Explanation

    A registrant that discovers a theft or significant loss must report it in writing to the DEA field office within one business day of discovery, using DEA Form 106. Insignificant losses are documented internally but are not reported to DEA.

  110. Question 110Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Which statement about the DEA Controlled Substance Ordering System (CSOS) is correct?

    1. It replaces Form 222 with an electronic Schedule II order Correct answer.
    2. It requires the purchaser to mail a paper Form 222 every month
    3. It may be used for Schedule III through V drugs but never Schedule II
    4. It may be used only by manufacturers and distributors

    Explanation

    CSOS permits a registrant to place electronic orders for Schedule I and II substances, substituting for the paper DEA Form 222. The purchaser must hold a valid DEA-issued digital certificate for the person signing the orders.

  111. Question 111Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A pharmacy's power of attorney to sign DEA Form 222 was granted to the pharmacy manager, who then left the company. How is that authority revoked?

    1. A signed notice of revocation kept on file Correct answer.
    2. The pharmacy must surrender the executed order forms to DEA
    3. DEA must approve the revocation in writing before it takes effect
    4. The authority ends automatically on the manager's last day of work

    Explanation

    A registrant may revoke a power of attorney at any time by executing a written notice of revocation. The revocation is retained on file with the power of attorney and the executed order forms; no DEA approval is required.

  112. Question 112Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Under federal law, a codeine-containing cough preparation is placed in Schedule V when the codeine content does not exceed:

    1. 90 mg per dosage unit
    2. 100 mg per 100 mL
    3. 500 mg per 100 mL
    4. 200 mg per 100 mL Correct answer.

    Explanation

    A preparation containing no more than 200 mg of codeine per 100 mL (or per 100 g) is Schedule V. Above that limit it is Schedule III, and a preparation containing more than 1.8 g of codeine per 100 mL is Schedule II.

  113. Question 113Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Testosterone and its esters are controlled in which schedule?

    1. Not controlled
    2. Schedule III Correct answer.
    3. Schedule II
    4. Schedule IV

    Explanation

    Testosterone and its esters are classified as Schedule III anabolic steroids. Schedule III also includes ketamine and many anabolic steroid products.

  114. Question 114Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Which of the following is a Schedule IV controlled substance?

    1. Zolpidem Correct answer.
    2. Testosterone
    3. Morphine
    4. Ketamine

    Explanation

    Zolpidem is a Schedule IV depressant, as are the benzodiazepines such as alprazolam and lorazepam. Ketamine and testosterone are Schedule III, and morphine is Schedule II.

  115. Question 115Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Pregabalin is classified in which schedule?

    1. Schedule III
    2. Schedule V Correct answer.
    3. Schedule IV
    4. Schedule II

    Explanation

    Pregabalin is a Schedule V controlled substance, the least restrictive schedule. Schedule V also includes low-dose codeine preparations and other products with a low potential for abuse.

  116. Question 116Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A Schedule II analgesic prescription is written for a patient in a long-term care facility, and the pharmacist dispenses a partial quantity. Within what period must the remaining quantity be supplied?

    1. 30 days
    2. 60 days Correct answer.
    3. 7 days
    4. 72 hours

    Explanation

    For partial fills of Schedule II prescriptions written for patients in a long-term care facility or receiving hospice care, the remaining quantity may be dispensed up to 60 days from the date the prescription was issued. After that a new prescription is required.

  117. Question 117Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A patient asks a community pharmacy to dispense only part of the quantity prescribed on a Schedule II prescription. The pharmacy is not supplying a long-term care or hospice patient. How long does the patient have to obtain the remainder?

    1. 30 days
    2. 72 hours Correct answer.
    3. 7 days
    4. The remainder may never be supplied

    Explanation

    In the ordinary outpatient setting, a partial fill of a Schedule II prescription must be completed within 72 hours of the partial dispensing. If the balance is not supplied within that period, the pharmacist must notify the prescriber, and a new prescription is needed.

  118. Question 118Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A patient wants to move an unfilled Schedule V prescription from Pharmacy A to Pharmacy B. Under federal rules, how many times may a Schedule III through V prescription be transferred between pharmacies?

    1. Twice
    2. Up to five times
    3. Unlimited until it expires
    4. One time only Correct answer.

    Explanation

    Federal rules allow a Schedule III through V prescription to be transferred between retail pharmacies one time only, provided the required documentation is recorded by both pharmacies. A second transfer of the same prescription is not permitted.

  119. Question 119Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A prescriber may fax a Schedule II prescription that serves as the original prescription in which situation?

    1. Any time the patient requests it
    2. The pharmacy and prescriber share the same electronic network
    3. For a long-term care or hospice patient Correct answer.
    4. The prescription is for less than a 14-day supply

    Explanation

    A faxed Schedule II prescription may serve as the original only for patients in a long-term care facility, patients receiving hospice care, and for home infusion or compounding for such patients. In other cases the fax is informational and the original must be presented before dispensing.

  120. Question 120Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A prescriber issues three separate 30-day prescriptions for a Schedule II stimulant at one visit so the patient can fill them over 90 days. What must each of the later prescriptions contain?

    1. The same fill date plus a note that it is part of a series
    2. A refill authorization of two
    3. A statement permitting early fills at the patient's request
    4. A distinct "do not fill before" date Correct answer.

    Explanation

    A prescriber may issue multiple Schedule II prescriptions covering up to a 90-day supply if each prescription bears a "do not fill before" date. The pharmacist must not dispense a prescription before that date.

  121. Question 121Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Which element is required on a Schedule II prescription?

    1. The prescriber's DEA number Correct answer.
    2. The pharmacy's DEA number
    3. The patient's insurance identifier
    4. The patient's diagnosis code

    Explanation

    A Schedule II prescription must include the prescriber's DEA registration number along with the patient's name and address, the drug name, strength, dosage form, quantity, directions, date, and signature. Diagnosis codes and insurance information are not federal requirements, and the pharmacy's own number does not belong on the prescription for this purpose.

  122. Question 122Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A pharmacy company operates two locations in the same city under the same ownership and wants to dispense controlled substances from both. What is required?

    1. One registration plus written notice to DEA about the second site
    2. Registration with the state board only
    3. One registration covering both sites under the same owner
    4. A separate DEA registration for each location Correct answer.

    Explanation

    Each principal place of business where controlled substances are stored or dispensed requires its own DEA registration and registration number. A separate certificate is issued for each registered location.

  123. Question 123Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A pharmacy sells single-ingredient pseudoephedrine tablets from behind the counter with logbook and identification requirements. Which statement best describes the product's federal status?

    1. CMEA rules apply, not CSA scheduling Correct answer.
    2. It is exempt from all federal requirements
    3. It is a Schedule V controlled substance
    4. It is a Schedule IV controlled substance

    Explanation

    Pseudoephedrine is a listed chemical regulated under the Combat Methamphetamine Epidemic Act, which imposes daily and monthly sales limits, logbook, and identification requirements. It is not a controlled substance under the Controlled Substances Act and has no DEA schedule.

  124. Question 124Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A pharmacy needs to dispose of a stock of expired oxycodone tablets. Which method is acceptable?

    1. Discard them in the regular trash after defacing the label
    2. Return them to the prescriber's office
    3. Flush them down the sink
    4. Send them to a DEA-registered reverse distributor Correct answer.

    Explanation

    Expired or unwanted controlled substances may be transferred to a DEA-registered reverse distributor for destruction, with the transaction documented. Sewer and trash disposal are not acceptable for most controlled substances, and practitioners generally may not take the drugs back.

  125. Question 125Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A drug has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety data for use under medical supervision. Into which schedule does it fall?

    1. Schedule III
    2. Schedule II
    3. Schedule IV
    4. Schedule I Correct answer.

    Explanation

    Schedule I is reserved for substances with high abuse potential, no currently accepted medical use, and no accepted safety data for use under medical supervision. Heroin and LSD are examples of Schedule I substances.

  126. Question 126Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A newly opened community pharmacy is applying for its initial DEA registration to dispense controlled substances. Which form does the pharmacy submit to DEA?

    1. DEA Form 225
    2. DEA Form 222
    3. DEA Form 224 Correct answer.
    4. DEA Form 106

    Explanation

    DEA Form 224 is the application for a new registration to dispense controlled substances, which is the category that applies to a community pharmacy. Form 222 is the order form for Schedule I and II substances, Form 225 is used by manufacturers and distributors, and Form 106 is the theft/loss report.

  127. Question 127Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    Under federal law, a prescription for a Schedule IV controlled substance may be refilled at most how many times, and within what period?

    1. Five refills within six months of the issue date
    2. Unlimited refills while the prescriber remains in practice
    3. No refills; a new prescription is required each time
    4. Two refills within one year of the issue date Correct answer.

    Explanation

    Rather than a two-refill limit, federal rules cap Schedule III and IV prescriptions at five refills, but no prescription in those schedules may be filled or refilled more than six months after its issue date. The combination of a refill count and a six-month outer limit defines the federal ceiling.

  128. Question 128Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A physician telephones a pharmacy with an emergency oral order for a Schedule II opioid because the patient cannot reach the office. The pharmacist dispenses a limited quantity. To keep the prescription valid, what must the prescriber do?

    1. Provide a written prescription within seven days Correct answer.
    2. Deliver a written prescription within 72 hours
    3. Provide a written prescription within 30 days
    4. Do nothing further; the oral order is the original prescription

    Explanation

    In a genuine emergency, a pharmacist may dispense a Schedule II substance on an oral order, but the prescriber must deliver a written prescription to the pharmacy within seven days. If the written prescription does not arrive, the pharmacist must notify the DEA field office.

  129. Question 129Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    A patient presents a written Schedule II prescription that reads "dispense #60," but the prescriber tells the pharmacist by telephone that the intended quantity was 30. Which action is permitted on the face of the prescription?

    1. Reduce the quantity dispensed from 60 to 30 after documenting the call Correct answer.
    2. Correct the spelling of the patient's name
    3. Substitute hydrocodone for the prescribed oxycodone because of a shortage
    4. Add a refill authorization for the remaining balance

    Explanation

    After consulting the prescriber and documenting the conversation, a pharmacist may add or change certain elements of a Schedule II prescription, including drug quantity, strength, dosage form, directions for use, and issue date. The patient's name, the drug itself, and the prescriber's signature may never be changed by the pharmacist.

  130. Question 130Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

    An adult nurse practitioner in private practice wants to prescribe Schedule II stimulants. Which statement about the prescribing authority is correct?

    1. A DEA registration alone authorizes the NP to prescribe every schedule
    2. The NP must register with the FDA instead of with DEA
    3. Only physicians may hold DEA registrations to prescribe Schedule II
    4. The NP must be state-authorized for that schedule and DEA-registered Correct answer.

    Explanation

    Prescribing authority is built on two layers: the practitioner must be licensed and authorized by the state to prescribe the particular schedule, and must separately hold a DEA registration for that schedule at the practice location. State authority that excludes Schedule II cannot be overridden by a DEA registration.

  131. Question 131Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Which of the following must appear on the label affixed to a prescription container when a medication is dispensed to a patient?

    1. Name of the patient Correct answer.
    2. Prescriber's DEA registration number
    3. Patient's insurance identification number
    4. Medical diagnosis being treated

    Explanation

    A dispensing label must identify the patient for whom the medication is intended, along with the drug, directions, pharmacy, prescription number, and related dispensing information. The diagnosis, insurance identifiers, and prescriber DEA number are not label elements.

  132. Question 132Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Under federal law, how many times may a prescription for a Schedule IV controlled substance be refilled, and within what period?

    1. No refills are permitted under any circumstances
    2. Three refills within one year of the date of issue
    3. Unlimited refills within six months of the date of issue
    4. Five refills within six months of the date of issue Correct answer.

    Explanation

    Prescriptions for Schedule III, IV, and V substances may be refilled up to five times within six months of the date the prescription was issued. After that, a new prescription is required.

  133. Question 133Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Which statement describes refilling of a Schedule II prescription under federal law?

    1. It may be refilled only if the prescriber obtains a new DEA number
    2. It may not be refilled Correct answer.
    3. It may be refilled once within six months with prescriber authorization
    4. It may be refilled up to five times within six months

    Explanation

    Federal regulations prohibit refilling any prescription for a Schedule II controlled substance. Additional quantities require a new prescription issued by the prescriber.

  134. Question 134Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Under the Poison Prevention Packaging Act, a prescription for an oral tablet must be dispensed:

    1. in a child-resistant container only when the patient has children living at home
    2. in a child-resistant container only if the prescriber specifically requests one
    3. in a conventional container whenever the patient is an older adult
    4. in a child-resistant container unless the patient or prescriber requests otherwise Correct answer.

    Explanation

    The Poison Prevention Packaging Act requires most oral prescription drugs to be dispensed in child-resistant packaging. Either the prescriber or the patient may request noncomplying packaging.

  135. Question 135Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Federal law requires that a patient package insert be dispensed with each prescription for which of the following?

    1. Metformin tablets
    2. Amoxicillin capsules
    3. Lisinopril tablets
    4. Oral contraceptives Correct answer.

    Explanation

    FDA regulations require patient package inserts for oral contraceptives and estrogen-containing drug products. Other drugs may require a Medication Guide, but not a patient package insert.

  136. Question 136Prescription processing, dispensing, labeling, counseling, and patient care obligations

    The OBRA-90 counseling mandate requires a pharmacist to offer counseling to which patients?

    1. Only patients receiving a prescription for the first time
    2. Only patients who specifically request counseling
    3. Only patients receiving a controlled substance
    4. Medicaid patients receiving a prescription Correct answer.

    Explanation

    OBRA-90 conditions Medicaid participation on a pharmacist's offer to counsel each Medicaid patient receiving a prescription. Many states extend the offer to all patients, but the federal mandate itself targets Medicaid beneficiaries.

  137. Question 137Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Under DEA regulations, who shares with the prescriber the responsibility for the proper prescribing and dispensing of controlled substances?

    1. The pharmacy technician who enters the order
    2. The pharmacist who dispenses the drug Correct answer.
    3. The patient's primary caregiver
    4. The wholesaler that distributed the drug

    Explanation

    The corresponding responsibility doctrine makes the dispensing pharmacist answerable, along with the prescriber, for ensuring that a controlled substance order serves a legitimate medical purpose. A pharmacist may not simply rely on a prescription's facial validity.

  138. Question 138Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Which element must be included on a written prescription for a Schedule II controlled substance?

    1. The prescriber's National Provider Identifier
    2. The patient's Social Security number
    3. The pharmacy's National Provider Identifier
    4. The prescriber's DEA registration number Correct answer.

    Explanation

    A prescription for a controlled substance must include the prescriber's DEA registration number so the pharmacy can verify registration and schedule authority. Patient Social Security numbers and NPI numbers are not required prescription elements.

  139. Question 139Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A pharmacist dispenses a Schedule II controlled substance on an oral emergency order. Within what period must the prescriber deliver a written prescription to the pharmacy?

    1. Fourteen days
    2. Seven days Correct answer.
    3. Twenty-four hours
    4. Thirty days

    Explanation

    For a genuine emergency, a pharmacist may dispense a Schedule II drug on an oral order if the prescriber delivers the written, signed prescription within seven days. The quantity dispensed is limited to the emergency period.

  140. Question 140Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A patient asks the pharmacist to partially fill a Schedule II prescription because the pharmacy does not have the full quantity. The remaining quantity must be dispensed no later than:

    1. 60 days after the date the prescription was written
    2. Six months after the date the prescription was written
    3. 30 days after the date the prescription was written Correct answer.
    4. 72 hours after the partial fill

    Explanation

    When a Schedule II prescription is partially filled at the patient's request or because of insufficient stock, the balance must be supplied within 30 days of the date the prescription was written. The 60-day window applies only to long-term care and terminally ill patients.

  141. Question 141Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Under federal law, how many times may a prescription for a Schedule IV controlled substance be transferred between pharmacies for refill purposes?

    1. Only after written DEA approval is obtained by both pharmacies
    2. One time Correct answer.
    3. Up to five times within a six-month period
    4. As many times as the patient requests within six months

    Explanation

    Federal rules permit a prescription for a Schedule III, IV, or V controlled substance to be transferred between pharmacies one time only, unless state law is more permissive. The transfer must be documented by both pharmacies.

  142. Question 142Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Which DEA form is used to order Schedule II controlled substances from a distributor?

    1. DEA Form 106
    2. DEA Form 222 Correct answer.
    3. DEA Form 41
    4. DEA Form 224

    Explanation

    Schedule II controlled substances are ordered from a distributer using DEA Form 222 (or its electronic equivalent, the CSOS). Form 41 covers destruction, Form 106 covers theft or loss, and Form 224 is a registration application.

  143. Question 143Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A Medication Guide must be provided to a patient:

    1. Only when the prescriber asks the pharmacist to provide it
    2. Only the first time the drug is dispensed to a given patient
    3. Routinely with each new and refill dispensing Correct answer.
    4. Only when the patient requests written information about the drug

    Explanation

    When FDA has approved a Medication Guide for a drug, the pharmacy must provide it with each dispensing, including refills, unless a documented exception applies. The obligation is not limited to first fills or to patient request.

  144. Question 144Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Under HIPAA, when a pharmacist discloses protected health information to another provider for treatment purposes, the pharmacist should disclose:

    1. The information only after notifying the patient in writing
    2. Nothing without a signed patient authorization
    3. The patient's entire prescription history
    4. Only the minimum information necessary Correct answer.

    Explanation

    HIPAA's minimum necessary standard requires that disclosures for treatment and other permitted purposes be limited to the information reasonably needed. Treatment disclosures still require appropriate safeguards such as secure transmission.

  145. Question 145Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Federal Medicaid law requires that written prescriptions be on a tamper-resistant pad:

    1. For all covered outpatient drugs unless a regulatory exception applies Correct answer.
    2. Only for controlled substances in Schedule II
    3. Only when the prescription is presented at an out-of-state pharmacy
    4. Only for beneficiaries who have not met their deductible

    Explanation

    Federal Medicaid rules require tamper-resistant prescription pads for all written, non-electronic Medicaid prescriptions for covered outpatient drugs, subject to limited exceptions such as faxed or verbal orders. The requirement applies regardless of drug class.

  146. Question 146Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A patient declines the pharmacist's offer to counsel on a new prescription. What should the pharmacist do?

    1. Document the refusal according to the pharmacy's policy Correct answer.
    2. Ask the prescriber to counsel the patient by telephone
    3. Refuse to dispense the medication until counseling occurs
    4. Counsel the patient's caregiver without informing the patient

    Explanation

    Counseling must be offered, not forced; a competent patient may decline. The pharmacist should record the refusal in the manner required by pharmacy policy and state rules.

  147. Question 147Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A pharmacist receives a cash-paid prescription for a large quantity of oxycodone from a prescriber located several hundred miles away. What is the pharmacist's most appropriate action?

    1. Resolve the concerns with the prescriber before dispensing Correct answer.
    2. Report the prescriber to DEA and dispense the drug
    3. Reduce the quantity dispensed without contacting the prescriber
    4. Dispense the prescription because it is valid on its face

    Explanation

    Unusual distance, cash payment, and large quantity are classic red flags; the pharmacist must resolve them before dispensing. Validating the prescription with the prescriber documents the corresponding responsibility analysis.

  148. Question 148Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A prescriber faxes a Schedule II prescription for a patient in a long-term care facility. Which statement is correct?

    1. The fax is valid only if the patient is terminally ill
    2. The fax may serve as the original prescription Correct answer.
    3. The fax is not valid and the pharmacy must wait for a mailed original
    4. The fax is valid only after DEA approves the arrangement

    Explanation

    Federal rules permit a faxed Schedule II prescription for a long-term care facility patient or a patient with a terminal illness to serve as the original prescription. No follow-up written document is required for those situations.

  149. Question 149Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A written prescription for a Schedule II controlled substance must be:

    1. signed and dated by the prescriber on the date it was issued Correct answer.
    2. dated no more than 30 days before it is presented
    3. signed by the prescriber's agent
    4. accompanied by a copy of the prescriber's medical license

    Explanation

    A Schedule II prescription must bear the prescriber's manual or electronic signature and the date it was issued. A prescription signed or dated on a different day, or signed by an agent, does not meet the requirement.

  150. Question 150Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Before dispensing a new prescription, the pharmacist should review the patient's profile for:

    1. the pharmacy's inventory level of the drug
    2. the prescriber's prescribing volume
    3. duplication, interactions, and allergies Correct answer.
    4. the patient's immunization history only

    Explanation

    Prospective drug utilization review screens the patient profile for therapeutic duplication, drug interactions, allergies, and dosing problems before dispensing. This review is a core patient care obligation of the dispensing pharmacist.

  151. Question 151Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A pharmacist partially fills a Schedule II prescription for a patient in a long-term care facility. The remaining portion may be dispensed no later than:

    1. Six months after the prescription date
    2. 72 hours after the partial fill is dispensed
    3. 60 days after the date the prescription was written Correct answer.
    4. 30 days after the date the prescription was written and partially filled

    Explanation

    For long-term care facility patients and patients with a terminal illness, the balance of a partially filled Schedule II prescription may be dispensed up to 60 days from the date the prescription was written. The 30-day limit applies to other partial fills.

  152. Question 152Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A pharmacist dispenses a Schedule II controlled substance on an oral emergency order but never receives the written prescription within seven days. What must the pharmacist do?

    1. Notify the DEA field division Correct answer.
    2. Report the prescriber to the state board of pharmacy
    3. Take no action, because the oral order remains valid indefinitely
    4. Reverse the claim and request a new prescription from the prescriber

    Explanation

    Federal regulations require the pharmacist to notify the nearest DEA field division when the prescriber fails to deliver the written prescription within the seven-day emergency window. The pharmacy must also maintain records documenting the emergency dispensing.

  153. Question 153Prescription processing, dispensing, labeling, counseling, and patient care obligations

    How long must a pharmacy retain controlled substance prescription records under federal law?

    1. Indefinitely, until the pharmacy closes
    2. Five years from the date of dispensing
    3. Two years from the date of dispensing Correct answer.
    4. One year from the date of dispensing

    Explanation

    DEA regulations require that controlled substance records, including prescriptions, be kept for at least two years and be readily retrievable for inspection. Some states impose longer retention periods that would then control.

  154. Question 154Prescription processing, dispensing, labeling, counseling, and patient care obligations

    DEA regulations for electronic prescribing of Schedule II controlled substances require the prescriber to use:

    1. A scanned signature stored on the pharmacy server
    2. Two-factor authentication using an approved credential Correct answer.
    3. A monthly paper confirmation mailed to DEA
    4. A shared password known only to the prescriber

    Explanation

    Electronic prescribing of controlled substances requires identity proofing and two-factor authentication combining elements such as something known, something held, and a biometric. A scanned signature or a shared password does not satisfy these requirements.

  155. Question 155Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Federal law allows a Schedule V controlled substance to be sold without a prescription only when:

    1. the drug is not an opioid and is sold in a pharmacy
    2. DEA has approved the pharmacy for exempt sales
    3. the sale is permitted by state law and required records are maintained Correct answer.
    4. the purchaser is at least 21 years old and signs a consent form

    Explanation

    A Schedule V product may be dispensed without a prescription only if the state permits it and the federal conditions are met, including minimum purchaser age, identification, and recordkeeping in a bound book. Otherwise a prescription is required.

  156. Question 156Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Which item is required by federal law to appear on the label of a prescription dispensed to a patient?

    1. The patient's diagnosis or indication for therapy
    2. Patient name, if stated on the prescription Correct answer.
    3. The prescriber's DEA registration number
    4. The wholesale acquisition cost of the dispensed drug

    Explanation

    Federal labeling requirements for prescription drugs dispensed to a patient include the pharmacy name and address, the prescription serial number, the date, the patient name if given on the prescription, the prescriber name, and the drug name, strength, and directions for use. Diagnosis and acquisition cost are not required label elements, and a DEA number is a registration credential rather than a required label item. State law may add further requirements such as expiration or beyond-use dating.

  157. Question 157Prescription processing, dispensing, labeling, counseling, and patient care obligations

    An adult patient asks the pharmacist to dispense a new prescription in a container that is not child-resistant. Under the Poison Prevention Packaging Act, how should the pharmacist respond?

    1. The pharmacist may dispense in a noncomplying container at the patient's request. Correct answer.
    2. The pharmacist must refuse unless the prescriber authorizes a noncomplying container.
    3. The pharmacist must dispense in a child-resistant container because federal standards cannot be waived.
    4. The pharmacist may dispense in a noncomplying container only if the patient signs a liability waiver.

    Explanation

    The Poison Prevention Packaging Act requires child-resistant packaging for most oral prescription drugs, but permits the purchaser to request a noncomplying container. The pharmacist may honor that request and may also provide a noncomplying container when the prescriber directs it. No waiver, prescriber authorization, or refusal is required when the patient makes the request.

  158. Question 158Prescription processing, dispensing, labeling, counseling, and patient care obligations

    Under federal law, a prescription for a Schedule IV controlled substance may be refilled:

    1. Five times within six months of the date of issue Correct answer.
    2. Five times within one year of the date of issue
    3. Three times within six months of the date of issue
    4. An unlimited number of times, provided each refill is documented

    Explanation

    Federal regulations limit refills of prescriptions for Schedule III and IV controlled substances to five refills, all of which must occur within six months of the date the prescription was issued. Refilling beyond that limit requires a new prescription from the prescriber. State law may be more restrictive and should also be checked.

  159. Question 159Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A prescriber writes a new prescription with the direction "Take 1 tablet QD." What is the pharmacist's most appropriate action?

    1. Contact the prescriber to verify and obtain an unambiguous direction Correct answer.
    2. Dispense the prescription and counsel the patient to take one tablet every other day
    3. Dispense as written, because QD is an accepted abbreviation meaning once daily
    4. Change the direction to once daily and initial the correction on the hard copy

    Explanation

    QD is on the list of error-prone abbreviations because it can be misread as QID (four times daily) or qod (every other day), and it is no longer an acceptable direction. The pharmacist must clarify the intent with the prescriber rather than guessing, since a pharmacist may not independently change a prescription's directions without prescriber authorization. The clarified direction should then be documented and used for labeling and counseling.

  160. Question 160Prescription processing, dispensing, labeling, counseling, and patient care obligations

    A patient presents a prescription for a drug whose REMS includes elements to assure safe use, such as enrollment in a registry and a documented negative pregnancy test. Before dispensing, what must the pharmacist confirm?

    1. That the patient's insurer has approved the drug by prior authorization
    2. That the pharmacy holds a separate DEA registration for the drug
    3. That the REMS-required documentation has been completed for this patient Correct answer.
    4. That the prescriber has signed a generic substitution waiver

    Explanation

    When a drug has a REMS with elements to assure safe use, dispensing is conditioned on specific actions such as prescriber and patient enrollment, counseling, documentation of test results, or registry checks. The pharmacist must verify that these required conditions are met before the product is dispensed. Insurance authorization, separate DEA registration, and substitution waivers are unrelated to REMS compliance.

  161. Question 161Licensure, registration, certification, and pharmacy operations/inventory management

    A pharmacy discovers that a quantity of oxycodone tablets is missing and cannot be accounted for. Which DEA form must the registrant use to report the theft or significant loss?

    1. DEA Form 106 Correct answer.
    2. DEA Form 41
    3. DEA Form 222
    4. DEA Form 224

    Explanation

    DEA Form 106 is the Report of Theft or Loss of Controlled Substances and is submitted to the DEA field office when a registrant discovers a theft or significant loss. DEA Form 41 records destruction, DEA Form 222 orders Schedule II substances, and DEA Form 224 is the application for a new DEA registration.

  162. Question 162Licensure, registration, certification, and pharmacy operations/inventory management

    How many refills may be authorized on a prescription for a Schedule II controlled substance?

    1. No refills Correct answer.
    2. Up to five refills within six months
    3. Up to three refills within three months
    4. One refill within six months

    Explanation

    Federal law prohibits refills on Schedule II prescriptions, so a new prescription is required for any additional dispensing. Schedule III and IV prescriptions may be refilled up to five times within six months.

  163. Question 163Licensure, registration, certification, and pharmacy operations/inventory management

    Under federal regulations, how long must a pharmacy retain controlled substance records such as DEA Form 222 and inventories?

    1. 3 years
    2. 2 years Correct answer.
    3. 1 year
    4. 5 years

    Explanation

    Federal regulations require that controlled substance records, including invoices, DEA Forms 222, inventories, and prescription records, be kept for at least two years and be available for inspection. State law may impose a longer retention period.

  164. Question 164Licensure, registration, certification, and pharmacy operations/inventory management

    Which document is required to order Schedule II controlled substances from a wholesaler?

    1. A state prescription blank
    2. DEA Form 106
    3. DEA Form 224
    4. DEA Form 222 Correct answer.

    Explanation

    DEA Form 222 (or its electronic CSOS equivalent) is the order form used to obtain Schedule I and II controlled substances from a supplier. Schedule III through V substances are ordered on ordinary invoices.

  165. Question 165Licensure, registration, certification, and pharmacy operations/inventory management

    How often must a DEA-registered pharmacy take an inventory of controlled substances?

    1. Every three years
    2. Every six months
    3. Every year
    4. Every two years Correct answer.

    Explanation

    A registrant must take a complete inventory of controlled substances every two years, beginning on the date the registrant first engaged in business and every two years thereafter. The inventory must be kept with the other required records.

  166. Question 166Licensure, registration, certification, and pharmacy operations/inventory management

    How often must a DEA registration for a pharmacy be renewed?

    1. Every 3 years Correct answer.
    2. Every year
    3. Every 2 years
    4. Every 5 years

    Explanation

    DEA registrations are issued for a period of 36 months, and registrants must renew before expiration to continue handling controlled substances. DEA typically sends a renewal notice before the expiration date.

  167. Question 167Licensure, registration, certification, and pharmacy operations/inventory management

    During a biennial inventory, which controlled substances must be counted exactly?

    1. Only Schedule V controlled substances
    2. All Schedule III through V controlled substances
    3. None, if purchase invoices are available
    4. All Schedule II controlled substances Correct answer.

    Explanation

    Schedule II substances must be counted exactly during the biennial inventory. Schedule III through V substances may be estimated unless a container holds more than 1,000 tablets or capsules, in which case an exact count is required.

  168. Question 168Licensure, registration, certification, and pharmacy operations/inventory management

    A pharmacist-in-charge wants another pharmacist to sign DEA Form 222 orders. What is required?

    1. The pharmacist must file DEA Form 224 with the state board
    2. The pharmacist must obtain a new DEA registration for that pharmacy location
    3. DEA must approve the pharmacist as a co-registrant before any order is signed
    4. A power of attorney kept on file at the pharmacy Correct answer.

    Explanation

    A registrant may authorize an agent to sign DEA Form 222 by executing a power of attorney, which is kept with the registrant's records and does not require DEA approval. The authorized agent may then sign orders on the registrant's behalf.

  169. Question 169Licensure, registration, certification, and pharmacy operations/inventory management

    A pharmacy destroys its expired Schedule II tablets on site using a compliant destruction method. Which DEA record documents the destruction?

    1. DEA Form 106
    2. DEA Form 224
    3. DEA Form 41 Correct answer.
    4. DEA Form 222

    Explanation

    DEA Form 41, the Registrant Record of Controlled Substances Destroyed, documents the date, method, and quantity of controlled substances destroyed by a registrant. Destruction must render the substances non-retrievable.

  170. Question 170Licensure, registration, certification, and pharmacy operations/inventory management

    A CSOS digital certificate issued to a signer for electronic Schedule II orders is generally valid for what period before renewal is required?

    1. 3 years Correct answer.
    2. 5 years
    3. 2 years
    4. 1 year

    Explanation

    CSOS digital certificates are valid for three years and must be renewed before they expire. The certificate holder's private key is used to sign electronic orders, and the certificate is revoked when the holder leaves the registrant's employ.

  171. Question 171Licensure, registration, certification, and pharmacy operations/inventory management

    A prescription for a Schedule IV controlled substance may be refilled how many times, and within what period?

    1. No refills
    2. Unlimited refills within one year
    3. Three refills within three months
    4. Five refills within six months Correct answer.

    Explanation

    Schedule III and IV prescriptions may be refilled up to five times, but not more than six months after the date of issue. Schedule V prescriptions may also be refilled under the same limits when a prescription is required.

  172. Question 172Licensure, registration, certification, and pharmacy operations/inventory management

    A prescriber gives an emergency oral order for a Schedule II controlled substance. Within what period must a written prescription be provided to the pharmacy?

    1. 30 days
    2. 5 days
    3. 7 days Correct answer.
    4. 72 hours

    Explanation

    When a pharmacist receives an emergency oral order for a Schedule II substance, the prescriber must provide a written or electronic prescription within seven days. If the prescription is not received, the pharmacist must notify DEA.

  173. Question 173Licensure, registration, certification, and pharmacy operations/inventory management

    Under DSCSA, which element is part of the transaction information that trading partners must exchange?

    1. The name and address of the seller Correct answer.
    2. The prescription number
    3. The patient's diagnosis and treatment plan
    4. The dispensing pharmacy's DEA number

    Explanation

    DSCSA transaction information must include the product identifier, the transaction date, and the name and address of the seller and purchaser, along with the seller's agent if applicable. Patient diagnosis and prescription numbers are not transaction information elements.

  174. Question 174Licensure, registration, certification, and pharmacy operations/inventory management

    An FDA recall of a drug that may cause serious adverse health consequences or death is classified as which class?

    1. Class IV
    2. Class I Correct answer.
    3. Class II
    4. Class III

    Explanation

    Class I recalls involve a reasonable probability that use of the product will cause serious adverse health consequences or death. Class II recalls involve temporary or reversible harm, and Class III recalls are unlikely to cause harm.

  175. Question 175Licensure, registration, certification, and pharmacy operations/inventory management

    A DEA-registered wholesale distributor identifies a suspicious order for a controlled substance. What must it do?

    1. Return the order to the manufacturer without documentation
    2. Report the order only to the state board of pharmacy
    3. Report the suspicious order to DEA Correct answer.
    4. Fill the order and document the review in the invoice file

    Explanation

    DEA-registered wholesale distributors must monitor and report suspicious orders of controlled substances to DEA. A suspicious order is one of unusual size, one that deviates from a normal pattern, or one that is otherwise unusual.

  176. Question 176Licensure, registration, certification, and pharmacy operations/inventory management

    A pharmacy chain opens a second location in the same city. Regarding DEA registration for controlled substances, the new location must:

    1. Notify DEA within 30 days but may start immediately
    2. Rely on the existing registration because both sites are in the same city
    3. Obtain a separate DEA registration for that location Correct answer.
    4. Operate under a separate state license only

    Explanation

    Each principal place of business where controlled substances are stored or dispensed must have its own DEA registration. A new location cannot operate under the registration of another pharmacy, even within the same city.

  177. Question 177Licensure, registration, certification, and pharmacy operations/inventory management

    A patient requests a partial fill of a Schedule II prescription. Within what period must the pharmacy supply the remaining quantity?

    1. 60 days
    2. 30 days
    3. 7 days
    4. 72 hours Correct answer.

    Explanation

    A Schedule II prescription may be partially filled at the request of the patient or prescriber, but the remaining quantity must be dispensed within 72 hours; if it is not, the prescriber must be notified. For patients in a long-term care facility or with a terminal illness, the remainder may be supplied within 60 days.

  178. Question 178Licensure, registration, certification, and pharmacy operations/inventory management

    Under DEA regulations, what standard must a controlled substance meet before it can be considered destroyed on site?

    1. Rendered unusable
    2. Returned to the wholesaler
    3. Diluted with water
    4. Non-retrievable Correct answer.

    Explanation

    Since the 2014 rule, controlled substances must be destroyed so that they are non-retrievable, meaning they cannot be transformed back into a usable form. This standard applies to on-site destruction and destruction through a reverse distributor.

  179. Question 179Licensure, registration, certification, and pharmacy operations/inventory management

    Which statement about controlled substance inventory records is correct?

    1. It must be signed and dated by the person who took it Correct answer.
    2. It is not required if perpetual inventory logs are maintained
    3. Only a DEA investigator signs the completed inventory
    4. It must be notarized and filed with the state board within 30 days

    Explanation

    The person who takes the inventory must sign and date it, and the inventory record must be kept for at least two years. It must be maintained at the registered location and be available for DEA inspection.

  180. Question 180Licensure, registration, certification, and pharmacy operations/inventory management

    Which statement about DEA Form 222 is correct?

    1. It must be notarized before the supplier may fill it
    2. It may be used to order Schedule II through Schedule V substances
    3. It cannot be used for Schedule III substances Correct answer.
    4. Any employee may sign it without written authorization

    Explanation

    DEA Form 222 is used only to order Schedule I and II controlled substances; Schedule III through V substances are ordered on ordinary invoices. The form must be signed by the registrant or a person holding a power of attorney.

  181. Question 181Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under the federal Combat Methamphetamine Epidemic Act, what is the maximum amount of pseudoephedrine a retail purchaser may obtain in a single day?

    1. 3.6 grams Correct answer.
    2. 7.5 grams
    3. 9 grams
    4. 1.2 grams

    Explanation

    The CMEA sets a daily sales limit of 3.6 grams of pseudoephedrine base and a 30-day limit of 9 grams. Retail sales require behind-the-counter storage, photo identification, and a written or electronic logbook entry.

  182. Question 182Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Which emergency contraceptive product is available over the counter without a prescription and without an age restriction in the United States?

    1. Ulipristal acetate 30 mg (ella)
    2. Copper intrauterine device
    3. Levonorgestrel 0.75 mg two-tablet regimen by prescription only
    4. Levonorgestrel 1.5 mg (Plan B One-Step) Correct answer.

    Explanation

    Levonorgestrel 1.5 mg emergency contraception is available OTC with no age restriction. Ulipristal acetate remains prescription-only, and the copper IUD is a clinician-inserted device.

  183. Question 183Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under USP <795>, what is the default beyond-use date for a nonsterile compounded oral preparation that contains water?

    1. 30 days when stored in the refrigerator
    2. 180 days at controlled room temperature
    3. 14 days when stored in the refrigerator Correct answer.
    4. 6 months when stored frozen

    Explanation

    USP <795> assigns a default BUD of 14 days refrigerated for water-containing oral nonsterile preparations. Nonaqueous preparations default to 180 days, and water-containing topical preparations default to 30 days.

  184. Question 184Compounding, nonprescription and behind-the-counter products, and special distribution channels

    A pharmacy transfers a stock bottle of oxycodone tablets to another DEA-registered pharmacy. Which document is required for this distribution?

    1. DEA Form 222 Correct answer.
    2. DEA Form 106
    3. DEA Form 41
    4. An invoice only

    Explanation

    Distribution of a Schedule II controlled substance between registrants requires a DEA Form 222 or an approved electronic CSOS order. Form 106 is for theft or significant loss, and Form 41 is for destruction.

  185. Question 185Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Which statement about naloxone nasal spray is correct?

    1. It is available over the counter without a prescription Correct answer.
    2. It is a Schedule V controlled substance kept behind the counter
    3. It may be sold only to patients with an opioid prescription
    4. It requires REMS certification of the pharmacy

    Explanation

    Naloxone nasal spray is available OTC and may be sold without a prescription. It is not a controlled substance and does not require patient-specific prescribing or REMS certification for routine OTC sale.

  186. Question 186Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under the Prescription Drug Marketing Act, which action is prohibited for prescription drug samples?

    1. Storing samples in a locked cabinet
    2. Selling samples to another pharmacy Correct answer.
    3. Recording each sample distribution
    4. Distributing samples to licensed practitioners

    Explanation

    The PDMA prohibits the sale, purchase, or trade of prescription drug samples. Samples may be distributed to licensed practitioners and must be stored and accounted for properly.

  187. Question 187Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Which situation most clearly allows a 503A pharmacy to compound a drug that is essentially a copy of a commercially available product?

    1. The commercial product is temporarily back ordered
    2. The pharmacy can sell the compounded version more cheaply
    3. The patient requests a different brand name
    4. The prescriber documents a clinical difference for the patient Correct answer.

    Explanation

    A compounded drug is not considered essentially a copy when a change produces a significant difference for an identified patient, such as a dosage form needed for a clinical reason. Lower price, brand preference, or temporary back order alone does not satisfy the exception.

  188. Question 188Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Before a 503A pharmacy compounds with a bulk drug substance, which condition must be met?

    1. It is approved in a new drug application for that use
    2. It is purchased from a licensed retail pharmacy
    3. Its manufacturer is FDA-registered and provides a certificate of analysis Correct answer.
    4. It is listed on a state board compounding formulary with a local review

    Explanation

    Bulk drug substances used in 503A compounding must meet standards such as USP monograph requirements, come from an FDA-registered establishment, and be accompanied by a valid certificate of analysis. FDA also maintains a list of bulk substances permitted for compounding.

  189. Question 189Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under USP <795>, what default beyond-use date applies to a nonaqueous nonsterile compounded preparation?

    1. 14 days
    2. 1 year
    3. 180 days Correct answer.
    4. 30 days

    Explanation

    The default BUD for a nonaqueous nonsterile preparation under USP <795> is 180 days. Shorter defaults apply to water-containing oral and topical preparations.

  190. Question 190Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under the Drug Supply Chain Security Act, a pharmacy may accept a prescription drug product only from which source?

    1. A foreign distributor approved by the manufacturer
    2. Any wholesaler offering a lower price
    3. An authorized trading partner with a valid license Correct answer.
    4. A patient returning an unopened package

    Explanation

    DSCSA requires trading partners to be authorized and to exchange transaction information. A pharmacy should not accept product from an unlicensed or unauthorized source.

  191. Question 191Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Which action is required before a pharmacy may dispense isotretinoin under the iPLEDGE program?

    1. The pharmacy must compound the drug from bulk powder
    2. The pharmacy must report each fill to the health department
    3. The pharmacy must be certified and verify patient enrollment Correct answer.
    4. The pharmacist must obtain a DEA Form 222

    Explanation

    Isotretinoin is subject to a REMS with elements to assure safe use. The pharmacy must be REMS-certified and must verify that the patient and prescriber meet enrollment and authorization requirements before dispensing.

  192. Question 192Compounding, nonprescription and behind-the-counter products, and special distribution channels

    A 340B covered entity's contract pharmacy must follow which rule?

    1. It may dispense 340B drugs to any patient regardless of eligibility
    2. It may use 340B drugs only for inpatient services
    3. It must prevent diversion of 340B drugs to ineligible patients Correct answer.
    4. It may resell 340B drugs to other pharmacies

    Explanation

    The 340B program prohibits diversion of discounted drugs to individuals who are not eligible patients of the covered entity. Contract pharmacies must have systems to identify eligible patients and prevent diversion.

  193. Question 193Compounding, nonprescription and behind-the-counter products, and special distribution channels

    A pharmacy has expired Schedule II tablets to destroy. Which arrangement complies with DEA regulations?

    1. Using a DEA-registered reverse distributor and a Form 222 Correct answer.
    2. Returning them to the wholesaler for credit without documentation
    3. Flushing them down the sink with water
    4. Mailing them to the manufacturer for disposal

    Explanation

    Expired Schedule II controlled substances may be transferred to a DEA-registered reverse distributor using a DEA Form 222 or CSOS order. Documentation and DEA-registered handling are required.

  194. Question 194Compounding, nonprescription and behind-the-counter products, and special distribution channels

    A manufacturer wants to switch a prescription drug to over-the-counter status. Which pathway is normally required?

    1. An abbreviated new drug application
    2. A 503B outsourcing facility registration
    3. A supplemental new drug application Correct answer.
    4. A new OTC monograph

    Explanation

    An Rx-to-OTC switch for an approved drug is generally accomplished through a supplemental new drug application. The OTC monograph system is used for ingredients that are generally recognized as safe and effective, not for switching an approved NDA drug.

  195. Question 195Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Which statement best describes a drug marketed under an FDA over-the-counter monograph?

    1. It is approved under a new drug application with a REMS
    2. It is exempt from good manufacturing practice
    3. It must be dispensed only by a pharmacist
    4. It is generally recognized as safe and effective Correct answer.

    Explanation

    An OTC monograph sets conditions under which a drug ingredient is generally recognized as safe and effective for its labeled use. Products meeting the monograph do not need an approved new drug application.

  196. Question 196Compounding, nonprescription and behind-the-counter products, and special distribution channels

    A 503A pharmacy compounds a batch of a sterile drug without patient-specific prescriptions to sell to a local clinic. Which statement is correct?

    1. It is not permitted because a patient-specific prescription is required Correct answer.
    2. It is permitted if the pharmacy limits the batch to 30 units
    3. It is permitted if the drug is on the FDA shortage list
    4. It is permitted if the clinic signs a purchase agreement

    Explanation

    The 503A exemption applies to compounding for an identified individual patient based on a valid prescription. Compounding in advance for office use without patient-specific prescriptions is characteristic of a 503B outsourcing facility, not a 503A pharmacy.

  197. Question 197Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under federal law, a 503A compounding pharmacy may distribute compounded drugs interstate only if which condition is met?

    1. It compounds only nonsterile preparations for local patients
    2. It sells only to licensed prescribers in its state
    3. It registers with the DEA as a wholesale distributor
    4. It meets the 5% limit or an FDA memorandum Correct answer.

    Explanation

    A 503A pharmacy may distribute compounded drugs out of state up to 5% of its total prescription orders unless it has entered into a memorandum of understanding with FDA addressing interstate distribution.

  198. Question 198Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Which statement about a 503B outsourcing facility is correct?

    1. It may sell to facilities without patient-specific prescriptions Correct answer.
    2. It may compound copies of commercial drugs without exception
    3. It may not distribute without a patient-specific prescription
    4. It is exempt from CGMP when compounding sterile drugs

    Explanation

    A 503B outsourcing facility may compound and distribute drugs to healthcare facilities without patient-specific prescriptions. It must still comply with CGMP and remains subject to the prohibition on compounding essentially copies unless an exception applies.

  199. Question 199Compounding, nonprescription and behind-the-counter products, and special distribution channels

    Under the Prescription Drug Marketing Act, which statement about reimportation of prescription drugs is correct?

    1. Only the original manufacturer may reimport its drugs Correct answer.
    2. A patient may reimport a 90-day supply for personal use
    3. A pharmacy may reimport drugs if they are cheaper abroad
    4. A wholesaler may reimport drugs with a state license

    Explanation

    The PDMA generally prohibits reimportation of prescription drugs into the United States except by the original manufacturer. State licensure or personal-use claims do not create a general reimportation exception.

MPJE flashcards

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Durham-Humphrey Amendment
1951 federal law that established the prescription-only drug category and allowed refills only when authorized by the prescriber.
Poison Prevention Packaging Act
Federal law requiring child-resistant containers for most prescription drugs and some OTCs, with exemptions and a patient or prescriber opt-out.
Risk Evaluation and Mitigation Strategy
FDA-required safety program using tools such as a Medication Guide, communication plan, or Elements to Assure Safe Use to manage serious drug risks.
Drug Supply Chain Security Act
Federal law requiring unit-level product identifiers, transaction data, suspect product verification, and licensure checks throughout the pharmaceutical distribution supply chain.
HIPAA minimum necessary
Standard requiring covered entities to limit uses and disclosures of protected health information to the least information needed, with exceptions for treatment disclosures.
Adulterated versus misbranded drug
Adulterated drugs are contaminated or made under substandard conditions; misbranded drugs bear false or inadequate labeling. Both support FDA enforcement action.
State pharmacy practice act
Statute that creates the board of pharmacy and defines pharmacy practice, licensure requirements, disciplinary authority, and delegated rulemaking power within the state.
Nonresident pharmacy license
Registration an out-of-state pharmacy must obtain from a state before shipping prescriptions to patients there, subject to that state's labeling and reporting rules.
PDMP query mandate
State requirement that prescribers or dispensers check the prescription drug monitoring program before prescribing or dispensing controlled substances, subject to state-specific exceptions.
Board rulemaking authority
Power of a board of pharmacy to adopt regulations interpreting the practice act; rules carry the force of law but cannot exceed statutory authority.
Interstate licensure reciprocity
Process by which a pharmacist obtains a license in an additional state through score transfer or licensure by reciprocity; no single national license exists.
DEA Form 222
Order document, or its CSOS electronic equivalent, used to obtain Schedule I or II substances; only the registrant or a Power of Attorney holder may execute it.
Schedule II partial fill
Allows less than the full quantity to be dispensed, with remaining amounts supplied within 60 days for LTCF or terminally ill patients, or within 72 hours otherwise.
Emergency oral Schedule II order
Permits dispensing only the quantity needed during the emergency, provided a written or electronic prescription reaches the pharmacy within seven days.
Schedule III-V refills
A prescription for these schedules may be refilled up to five times, but not after six months from the date the prescription was issued.
DEA Form 106
Report submitted to the DEA field division documenting theft or significant loss of controlled substances, with a copy retained by the registrant.
Biennial controlled substance inventory
Complete count of all controlled substances every two years; Schedule II counted exactly, others estimated unless a container exceeds 1,000 units.
Dispensed label requirements
Must show pharmacy name and address, prescription number, date, patient name, directions, prescriber name, and drug name, strength, and quantity.
Prospective drug use review
Screening of a prescription before dispensing for therapeutic duplication, interactions, allergies, and dosing problems, required under OBRA 1990 for Medicaid patients.
Medication Guide
FDA-approved patient labeling for specified drugs that must be given with each dispensing, often as a REMS element.
Refusal to fill
A pharmacist's professional judgment decision not to dispense; the prescription must be returned to the patient and the reason documented where state law requires.
Prescriber authority verification
Confirmation that the prescriber holds a valid state license and DEA registration before a controlled substance prescription is dispensed.
DEA Power of Attorney
Written authorization letting a named agent execute DEA Form 222 orders for a registrant; retained with the executed order forms.
Perpetual controlled substance inventory
Running record of receipts and dispensings of controlled substances, used to detect losses and reconcile against the biennial physical inventory.
Continuing education requirement
State-mandated hours of approved CE per license renewal cycle, often including specified hours in pharmacy law or patient safety.
Technician registration ratio
State rule limiting how many registered technicians may work per pharmacist and defining the supervision and task-delegation requirements.
DEA Form 41
Form documenting the destruction of controlled substances, completed and retained by the registrant as part of required recordkeeping.
503A compounding pharmacy
State-licensed pharmacy compounding under patient-specific prescriptions; it may not regularly compound copies of commercially available drugs or in inordinate amounts.
503B outsourcing facility
FDA-registered facility that compounds without patient-specific prescriptions and must follow current good manufacturing practice and federal reporting requirements.
USP <797>
Standards for sterile compounding covering facility design, environmental monitoring, personnel training, and assignment of beyond-use dates by risk category.
USP <800>
Standards for handling hazardous drugs, requiring containment ventilated enclosures, closed system transfer devices, protective equipment, and designated storage.
Pseudoephedrine sales limit
Federal CMEA limit of 3.6 grams per day and 9 grams per 30 days per purchaser, with photo identification and a written or electronic logbook.

MPJE study guide

Federal Statutes, Regulations, and Agency Guidance

Who regulates what

Federal law governs the drug product and the closed chain of distribution; the states govern the practice of pharmacy. Knowing which actor a statute addresses is the entire game. The FD&C Act controls approval status, adulteration (cGMP failures, contamination, insanitary handling) versus misbranding (false or misleading labeling, missing required label information, dispensing a prescription drug without a valid prescription). The CSA controls scheduled substances. The PPPA sets child-resistant packaging standards, with narrow exceptions such as a patient or prescriber request. The Prescription Drug Marketing Act governs drug samples and forbids their resale. The DSCSA requires authorized trading partners, product tracing (transaction information, history, statement), verification of suspect and illegitimate product, and proper handling of saleable returns. The CMEA restricts pseudoephedrine sales. OBRA-90 requires prospective drug utilization review and an offer to counsel for Medicaid patients. HIPAA limits uses and disclosures of protected health information.

Traps

The FDA does not license pharmacies or pharmacists and does not regulate how a prescriber chooses therapy: off-label prescribing is lawful. An FDA-approved drug is still misbranded if dispensed without a required prescription. Guidance documents and warning letters are not statutes; guidance is nonbinding. Federal obligations stack on top of state ones rather than replacing them.

Rule of thumb

Ask who the statute addresses. "May this person prescribe, dispense, or counsel?" is state board territory. "Is this product adulterated, misbranded, or properly traced?" is FDA territory. "How must this controlled substance be ordered, stored, and recorded?" is DEA territory.

Worked example

A prescriber writes for an FDA-approved drug for a use not in its labeling. The pharmacist may dispense on a valid prescription; the FDA regulates manufacturer promotion, not the prescriber's practice.

Jurisdiction-Specific Statutes, Board Rules, and Regulatory Guidance

The state layer

Every state has a pharmacy practice act (statute) and board regulations (rules). Statutes outrank rules, and a rule that conflicts with its statute is invalid. The practice act supplies the definitions that drive exam questions: what counts as the practice of pharmacy, dispensing, compounding, and pharmacist care; who may own a pharmacy; what a pharmacist-in-charge must do; technician registration and permitted tasks; ratios; immunization and collaborative practice authority; emergency refills; therapeutic interchange and generic substitution; nonresident pharmacy registration; PDMP query and reporting duties; CE hours and renewal cycles; and grounds for discipline.

State controlled substance schedules can depart from federal ones (a drug may be scheduled by the state, or placed in a different schedule), and state rules frequently add requirements the CSA does not: prescription expiration dates, PMP checks before dispensing, quantity limits, and prescriber-ID rules.

Traps

Questions often hinge on a jurisdiction cue in the stem. "Federal" points to the CSA; "in this state" points to your board's rules, which you are expected to know cold. The most common error is assuming federal permission equals state permission. Where both apply, comply with the stricter requirement: a DEA registration confers no authority to dispense without a valid state license, and a state license does not excuse a federal violation. Watch also for rules that impose obligations on the pharmacy (records, security, signage) rather than on the pharmacist personally.

Rule of thumb

The federal rule is a floor, not a ceiling. If federal law permits and state law prohibits, you may not; if state law is silent, the federal rule controls.

Worked example

A pharmacist holds a DEA registration and a valid license in State A, and is asked to verify prescriptions at a State B pharmacy by remote connection. State B's practice act and nonresident/in-state licensure rules decide whether that is permissible; DEA registration is irrelevant to that question.

Controlled Substances: Scheduling, Registration, Ordering, Recordkeeping, and Prescriptions

The CSA framework

Schedules I through V rest on three findings: abuse potential, accepted medical use, and dependence liability. Schedule I has no accepted medical use. Registration is location-specific (each principal place of business), renewed every three years, with a power of attorney for agents; practitioners also need state authority to prescribe. Since the MATE Act, practitioners must attest to training on substance use disorder at registration and renewal.

Ordering and records

Schedule II is ordered on DEA Form 222 (single-sheet, or CSOS electronically) and cannot be ordered on an invoice; Schedules III-V move on invoices. Take an initial inventory when first registered and a biennial inventory thereafter, exact counts for Schedule II and estimated counts for III-V. Keep records two years and keep Schedule II records separate or readily retrievable. Report theft or significant loss on DEA Form 106 within one business day of discovery; destroy on Form 41, typically through a reverse distributor.

Prescriptions

Schedule II: no refills; an emergency oral order must be followed by a written or electronic prescription within seven days. Partial fills: the balance within 72 hours, or up to 60 days for long-term care residents and terminally ill patients. Schedules III-V: up to five refills within six months of issue. The CMEA limits pseudoephedrine to 3.6 g per day and 9 g per 30 days, with logbook, identification, and two-year retention.

Traps

A pharmacist has independent "corresponding responsibility" for red flags even on a facially valid prescription. An expired-looking Schedule II prescription is a state question, not a federal one. Federal rules now allow a one-time transfer of an unfilled electronic Schedule II prescription between retail pharmacies for initial filling, but state law may not.

Rule of thumb

Remember 2-2-2: two years of records, biennial inventory, Form 222 for Schedule II only.

Prescription Processing, Dispensing, Labeling, Counseling, and Patient Care

A valid prescription

Screen for the essential elements: patient identity, drug, strength, dosage form, quantity, directions, date, prescriber identity and signature (or valid electronic signature), and refills authorized. An electronic prescription for a controlled substance requires EPCS-compliant two-factor authentication and an audit trail. A pharmacist may not add or change a prescriber-authored element; missing essential information makes the prescription invalid until the prescriber supplies it.

Label versus labeling

Label means the container label; labeling means everything else that accompanies the product. The label must carry the pharmacy name and address, prescription number, date, prescriber, patient, directions, and required cautionary statements; state boards add items. Counseling duties usually arise as an offer to counsel on every new prescription, with documentation when the patient declines. OBRA-90 mandates prospective drug utilization review and an offer to counsel for Medicaid; most states require it for all patients. Medication Guides and REMS materials follow the product, not the payer.

Traps

Do not confuse refill-too-soon adjudication edits with legal authority, or quantity with days' supply. Red flags for controlled substances (early refills, cash payment, distance, pattern prescribing) trigger a duty to resolve before dispensing. Document clarifications, counseling refusals, and prescriber conversations. Remember that partial fills are lawful for non-controlled prescriptions and have their own controlled substance rules.

Rule of thumb

When a required element is missing or a red flag is unresolved, do not fix it yourself: contact the prescriber and document the resolution before dispensing.

Licensure, Registration, Certification, and Operations/Inventory Management

Three different words

License is state-granted authority to practice or operate (pharmacist license, pharmacy or facility license, nonresident pharmacy registration). Registration is an enumerated listing with a government agency (DEA registration, state technician registration, with some states also requiring certification). Certification is a private credential (PTCB or ExCPT) that does not by itself authorize practice. Mixing these three is the single most common source of missed items in this domain.

Pharmacist-in-charge and operations

The PIC is accountable for compliance: current licenses, training records, security (substantial deterrence, limited keys, alarm, access control), self-inspections, and record retention. Continuing education, renewal, and reinstatement requirements live here, as do technician ratio and task limits. Federal controlled substance records run two years; state retention rules are often longer and control.

Inventory and product handling

Beyond the controlled substance inventory, operations questions test recalls, returns, and dating. Recall classes: Class I is reasonable probability of serious harm or death, Class II temporary or reversible harm, Class III unlikely harm. Expired or recalled stock is quarantined, not sold. Returns of controlled substances generally go to a reverse distributor on Form 222 for Schedule II. Dispensed medications may not be returned to stock under most state rules, and DSCSA restricts returns of product that has left the trading chain.

Traps

A DEA registration does not authorize practice without a state license, and a technician certification does not create practice authority where the state requires registration. Nonresident pharmacies must register in each state they ship into.

Rule of thumb

Sort every fact into three boxes before answering: government authority to practice, government listing, or private credential.

Compounding, Nonprescription/BTC Products, and Special Distribution Channels

503A versus 503B

The dividing question is whether the preparation is patient-specific and prescription-based. A 503A traditional compounder is a licensed pharmacy or federal facility that compounds on a patient-specific prescription or a documented prescriber-established relationship; it must avoid "essentially a copy" of a commercially available product unless a change produces a significant difference for the patient; bulk drug substances must comply with an applicable USP/NF monograph and appear on FDA's 503A bulks list with a certificate of analysis from a registered establishment; out-of-state distribution is capped absent an MOU; and USP <795> (nonsterile), <797> (sterile), and <800> (hazardous) standards apply. A 503B outsourcing facility registers with FDA, follows cGMP, may compound without patient-specific prescriptions, must use substances on the 503B bulks list, and reports adverse events. State boards still regulate the practice.

Nonprescription and behind-the-counter

OTC status comes from an FDA monograph (GRASE) or an NDA switch. Behind-the-counter is not an FDA category; it is a state or federal restriction layered on an OTC product, most notably CMEA pseudoephedrine (logbook, ID, daily and 30-day limits) and age-restricted emergency contraception. Dietary supplements under DSHEA are not FDA-approved.

Special channels

Drug samples move under the PDMA with prescriber requests and no resale. Restricted distribution systems (iPLEDGE, clozapine REMS, limited-distribution products), 340B, mail order, and VA/DOD channels each carry their own documentation duties.

Traps

Compounded preparations still need a label with a beyond-use date. Bulk substance lists differ between 503A and 503B, so a substance legal for one pathway may be illegal for the other.

Rule of thumb

No list, no bulk: if the substance is not on the applicable FDA bulks list, do not compound from bulk.

MPJE cheat sheet

Quick reference

Federal Statutes, Regulations, and Agency Guidance Affecting Pharmacy Practice

  • Durham-Humphrey Amendment (1951) created the prescription-only legend category and permits refills only when the prescriber authorizes them; drugs not safe for lay self-use require a prescription.

  • The Controlled Substances Act (CSA) creates a closed system of distribution: every Schedule I-V handler must be registered with DEA, and all transfers are documented on DEA forms or electronic equivalents.

  • DEA registrations run three years and are site-specific; a separate registration is required for each principal place of business, including separate dispensing and distribution locations.

  • DSCSA requires unit-level product identifiers, transaction data exchange, verification of suspect or illegitimate product, and authorized-trading-partner licensure checks; records must be retained 6 years.

  • REMS tools are limited to a Medication Guide, patient package insert, communication plan, and Elements to Assure Safe Use (ETASU) such as prescriber certification or restricted dispensing.

  • HIPAA requires a good-faith breach risk assessment; individual notice is due without unreasonable delay and no later than 60 days after discovery, with HHS notice for breaches affecting 500 or more individuals.

  • USP <795>, <797>, and <800> become federally enforceable through FDA and state adoption; <797> governs sterile compounding, <795> nonsterile, and <800> hazardous drugs.

  • Poison Prevention Packaging Act requires child-resistant containers for most oral prescription drugs; patients or prescribers may request non-child-resistant packaging.

Quick reference

Jurisdiction-Specific Pharmacy Statutes, Board Rules, and Regulatory Guidance

  • A state board of pharmacy derives all authority from the state pharmacy practice act; board rules interpret the statute and cannot exceed or conflict with it.

  • An out-of-state pharmacy shipping prescriptions into a state generally must hold a nonresident pharmacy license there and follow that state's labeling, counseling, and reporting rules.

  • State PDMP query mandates vary: some require a check before every controlled substance dispensing, others only on initial opioid prescriptions, with defined exceptions for hospice and LTCF.

  • Immunization authority is state-granted; pharmacists typically vaccinate under a protocol, standing order, or prescriber agreement, with age limits and reporting to the state immunization registry set by rule.

  • Prescription retention periods are set by state rule, commonly two years for non-controlled and two years for controlled substance records, with some states requiring longer.

  • Generic substitution is a state-law decision: many states require substitution of therapeutic equivalents unless the prescriber writes 'dispense as written' or the patient refuses.

  • There is no national pharmacist license; a pharmacist must hold a license in each state where practice occurs, obtained by score transfer or licensure by reciprocity.

Quick reference

Controlled Substances: Scheduling, Registration, Ordering, Recordkeeping, and Prescription Requirements

  • Schedule II prescriptions may not be refilled; Schedule III-V prescriptions allow up to five refills within six months of the date issued.

  • A Schedule II prescription may be partially filled only in limited cases: 30 days for LTCF or terminally ill patients, 72 hours for other partial fills, and remaining quantities for LTCF/terminally ill must be supplied within 60 days of the date written.

  • Emergency oral Schedule II orders: the pharmacist may dispense only the quantity needed for the emergency period, and the prescriber must furnish a written or electronic prescription within 7 days.

  • Schedule II substances are ordered on DEA Form 222 or through CSOS; only the registrant or a holder of a valid Power of Attorney may execute the order.

  • DEA Form 106 reports theft or significant loss to the local DEA field division; DEA Form 41 documents destruction of controlled substances.

  • Controlled substance records must be kept for at least two years and a biennial inventory is required, with Schedule II counted exactly and Schedules III-V estimated unless a container holds more than 1,000 units.

  • Schedule II prescriptions must be written, typed, or electronic, and a pharmacist may not fill a prescription issued more than 90 days earlier unless state law permits otherwise.

  • Federal law allows transfer of electronic controlled substance prescriptions between retail pharmacies for initial filling only, one time.

Quick reference

Prescription Processing, Dispensing, Labeling, Counseling, and Patient Care Obligations

  • A valid prescription requires the patient name, drug name, strength, dosage form, quantity, directions, prescriber name and address, and date of issue.

  • The dispensed label must include the pharmacy name and address, prescription number, date, patient name, directions for use, prescriber name, and drug name with strength and quantity.

  • OBRA '90 requires a prospective drug use review and an offer to counsel (with documented acceptance or refusal) for Medicaid-covered prescriptions, and most states extend this to all patients.

  • Medication Guides are FDA-approved patient labeling required for specified drugs and must accompany each dispensing when the REMS requires it.

  • A pharmacist may refuse to fill a prescription on professional judgment grounds but must return the prescription to the patient and, in many states, document the reason and notify the prescriber.

  • Pharmacists must verify that a prescriber holds a valid state license and a valid DEA number before dispensing a controlled substance.

  • Prescription transfers between pharmacies are permitted for refills of non-controlled drugs; controlled substance transfers are restricted and generally limited to a single transfer of an electronic prescription for initial filling.

Quick reference

Licensure, Registration, Certification, and Pharmacy Operations/Inventory Management

  • Personnel credentials commonly include pharmacist license, technician registration or certification, intern registration, and pharmacy permit, plus DEA and state controlled substance registrations.

  • A DEA Power of Attorney authorizes an agent to execute Form 222 orders; the POA must be retained with the executed order forms and be available for inspection.

  • Biennial controlled substance inventory must be taken on the date the registrant chooses, kept at the registered location, and retained for at least two years.

  • Continuing education requirements, hours per renewal cycle, and mandatory topic hours (law, patient safety, opioids) are set by each state board.

  • Schedule II receiving and dispensing are typically tracked on a perpetual or running inventory to detect and reconcile losses.

  • Theft or significant loss of controlled substances must be reported to DEA on Form 106 and to the state board within the time frame set by state rule.

  • Expired or unusable controlled substances cannot be returned to a wholesaler without DEA authorization and must be destroyed in a manner documented on Form 41 or through reverse distribution.

Quick reference

Compounding, Nonprescription and Behind-the-Counter Products, and Special Distribution Channels

  • A 503A compounder operates under a state pharmacy license and patient-specific prescriptions, and cannot regularly compound copies of commercially available drugs or in inordinate amounts.

  • A 503B outsourcing facility registers with FDA, may compound without patient-specific prescriptions, and must comply with current good manufacturing practice and reporting requirements.

  • USP <795> governs nonsterile compounding (facility, equipment, master formulation records, beyond-use dating); USP <797> governs sterile compounding and assigns Category 1, 2, and 3 beyond-use dates.

  • USP <800> requires hazardous drug handling controls including containment ventilated enclosures, closed system transfer devices, personal protective equipment, and designated storage.

  • The Combat Methamphetamine Epidemic Act limits retail pseudoephedrine sales to 3.6 g per day and 9 g per 30 days, requires photo identification, a written or electronic logbook, and restricts package access.

  • Behind-the-counter products such as pseudoephedrine and some emergency contraceptives are sold without a prescription but require pharmacist involvement, recordkeeping, or proof of age.

  • Prescription Drug Marketing Act restricts drug samples: they may be distributed only to licensed practitioners and may not be sold, traded, or resold.

  • Special distribution channels include DSCSA-licensed wholesalers, VA and Indian Health Service facilities, and limited-distribution or REMS-restricted products available only through certified sites.

MPJE key terms

Food, Drug, and Cosmetic Act

The principal federal statute governing drug safety, effectiveness, labeling, and manufacturing. It authorizes FDA oversight and sets requirements pharmacies must meet when dispensing, repackaging, or distributing drugs.

Related: Durham-Humphrey Amendment, Drug Supply Chain Security Act (DSCSA)
Durham-Humphrey Amendment

1951 amendment to the federal Food, Drug, and Cosmetic Act that created the prescription-only drug category and required the legend "Caution: Federal law prohibits dispensing without a prescription" on such drugs.

Related: Food, Drug, and Cosmetic Act
Risk Evaluation and Mitigation Strategy (REMS)

An FDA-required safety program for certain drugs; it may require prescriber training, patient enrollment, or restricted distribution, and pharmacies sometimes need certification before they can dispense.

Related: MedWatch
MedWatch

The FDA's program for reporting serious adverse events, product quality defects, and medication errors. Reporting by pharmacists is generally voluntary and submitted on Form 3500 or 3500B.

Related: Risk Evaluation and Mitigation Strategy (REMS)
Drug Supply Chain Security Act (DSCSA)

Federal law requiring an interoperable electronic system to trace prescription drugs through the supply chain, using transaction information, product identifiers, and verification of trading partners.

Related: Food, Drug, and Cosmetic Act
Poison Prevention Packaging Act (PPPA)

Federal law requiring child-resistant packaging for most oral prescription drugs and some over-the-counter products, with exemptions when the prescriber or the patient requests easier-to-open packaging.

Related: Prescription label requirements
HIPAA Privacy Rule

Federal regulation limiting use and disclosure of protected health information by covered entities such as pharmacies; it permits disclosures for treatment, payment, and operations and requires safeguards and patient notice.

Combat Methamphetamine Epidemic Act (CMEA)

Federal law imposing daily and monthly purchase limits, photo-identification logbook entries, and behind-the-counter storage rules on ephedrine and pseudoephedrine products sold without a prescription.

Related: Behind-the-counter (BTC) product
Unprofessional conduct

Behavior that violates accepted pharmacy practice standards, such as dispensing without a valid prescription, practicing while impaired, or falsifying records; it is grounds for board discipline.

Related: Pharmacist-in-charge (PIC)
Prescription Drug Monitoring Program (PDMP)

A state-operated database that collects dispensing data for controlled substances; pharmacists report each dispensing and must review the database in the circumstances their state law specifies.

Related: Schedule II, Red flag
Controlled Substances Act (CSA)

Federal statute that places drugs into five schedules by abuse potential and medical use, and sets registration, ordering, security, inventory, and prescription rules enforced by DEA.

Related: Schedule II, DEA registration
Schedule II

Controlled substances with high abuse potential, severe dependence liability, and accepted medical use; they require a written or electronic prescription, allow no refills, and carry stricter storage and recordkeeping duties.

Related: DEA Form 222, Partial filling, Emergency oral prescription
DEA registration

Required federal registration for practitioners and pharmacies that handle controlled substances; it is site-specific, renewed every three years, and must be updated when the address or ownership changes.

Related: Controlled Substances Act (CSA), Power of attorney (DEA)
DEA Form 222

The order form used to obtain Schedule I and II controlled substances from a supplier; purchaser and supplier each retain copies, and electronic ordering may replace the paper form.

Related: Controlled Substance Ordering System (CSOS), Power of attorney (DEA)
Controlled Substance Ordering System (CSOS)

DEA-approved electronic ordering that replaces the paper Form 222 for Schedule I and II drugs, using digital certificates and electronic signatures to authenticate each order.

Related: DEA Form 222
DEA Form 41

The DEA form documenting destruction or surrender of controlled substances; the registrant records the drug, quantity, and witnesses, and must also follow applicable state destruction rules.

Related: Biennial inventory
DEA Form 106

Report of Theft or Loss used to notify DEA of stolen or significantly lost controlled substances; the registrant keeps a copy, and state authorities may require separate notice.

Related: Biennial inventory
Biennial inventory

A complete count of all controlled substances on hand, taken at least every two years; Schedule II drugs are counted exactly, while others may be estimated unless a container holds more than 1,000 units.

Related: DEA Form 41, DEA Form 106
Power of attorney (DEA)

Written authorization by which a DEA registrant lets an employee sign controlled substance order forms; the document is kept on file with the executed order forms.

Related: DEA Form 222
Corresponding responsibility

The pharmacist's legal duty to judge that a controlled substance prescription was issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice.

Related: Red flag, Schedule II
Red flag

A circumstance suggesting a controlled substance prescription may be invalid, such as a long-distance prescriber, cash payment, early refills, or unusual patterns; it must be resolved before dispensing.

Related: Corresponding responsibility, Prescription Drug Monitoring Program (PDMP)
Partial filling

Dispensing less than the prescribed quantity; for Schedule II the remainder is generally supplied within 72 hours, or within 60 days when the patient is in long-term care or terminally ill.

Related: Schedule II, Emergency oral prescription
Emergency oral prescription

A Schedule II drug may be dispensed on an oral order in a genuine emergency, limited to the emergency period, if the prescriber delivers a written prescription within seven days.

Related: Schedule II, Partial filling
Six-month, five-refill rule

Federal limit on Schedule III through V prescriptions: they may not be filled or refilled more than six months after the issue date and may be refilled no more than five times.

Related: Schedule II
Electronic prescribing of controlled substances (EPCS)

Electronic prescribing of controlled substances under DEA rules, requiring identity proofing, two-factor authentication, and pharmacy verification of the prescriber's digital signature and records.

Related: Six-month, five-refill rule, DEA registration
Prescription label requirements

Information that must appear on a dispensed outpatient prescription label, including pharmacy name and address, prescription number, date, patient name, directions for use, prescriber, and required cautionary statements.

Related: OBRA-90 counseling, Poison Prevention Packaging Act (PPPA)
OBRA-90 counseling

Federal Medicaid law requiring pharmacists to offer counseling on new prescriptions and to perform prospective drug review; most states have extended the counseling duty to all patients.

Related: Prospective drug utilization review (DUR), Prescription label requirements
Prospective drug utilization review (DUR)

Review of a prescription before dispensing to identify therapeutic duplication, drug interactions, contraindications, wrong dose, or abuse, with the pharmacist resolving problems before the drug is released.

Related: OBRA-90 counseling, Orange Book
Orange Book

FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, listing products rated therapeutically equivalent; pharmacists use these ratings when selecting generic substitutes permitted by state law.

Related: Prospective drug utilization review (DUR)
Pharmacist-in-charge (PIC)

The pharmacist designated as responsible for a pharmacy's day-to-day compliance with drug laws and board rules, including recordkeeping, security, and supervision of pharmacy personnel.

Related: Unprofessional conduct, Pharmacy technician registration
Licensure by reciprocity

Obtaining a license in a new state based on an existing license in good standing and required examination scores, subject to that state's eligibility, fee, and jurisprudence requirements.

Related: Continuing education
Continuing education

Approved education hours a licensee must complete during each renewal cycle, often including mandated topics such as pharmacy law, opioid prescribing, or patient safety.

Related: Licensure by reciprocity
Pharmacy technician registration

Board-issued credential allowing a technician to assist in pharmacy practice under pharmacist supervision; requirements typically include training, criminal background checks, and periodic renewal.

Related: Pharmacist-in-charge (PIC)
USP <795>

United States Pharmacopeia chapter setting standards for nonsterile compounding, covering facility design, equipment, personnel training, master formulation records, and assignment of beyond-use dates.

Related: Beyond-use date, 503A compounding pharmacy
USP <797>

Chapter establishing standards for sterile compounding, including cleanroom classifications, environmental monitoring, gowning, personnel qualification, and validation of sterilization and aseptic technique.

Related: 503B outsourcing facility, USP <795>
USP <800>

Chapter on safe handling of hazardous drugs, covering containment and ventilation, closed system transfer devices, personal protective equipment, deactivation and cleaning, and worker medical surveillance.

Related: USP <797>
503A compounding pharmacy

A state-licensed pharmacy or physician that compounds for identified individual patients under a valid prescription and meets conditions that exempt it from certain federal manufacturing requirements.

Related: USP <795>, 503B outsourcing facility
503B outsourcing facility

An entity that compounds sterile drugs, may ship without patient-specific prescriptions, must register with FDA, follow current good manufacturing practice, and report the products it makes.

Related: USP <797>, 503A compounding pharmacy
Beyond-use date

The date after which a compounded preparation may no longer be used; it is assigned from USP standards based on water content, storage conditions, and container type.

Related: USP <795>, 503A compounding pharmacy
Behind-the-counter (BTC) product

Nonprescription products kept behind the counter rather than on open shelves; they may require pharmacist assistance, age verification, or recordkeeping but legally do not need a prescription.

Related: Combat Methamphetamine Epidemic Act (CMEA)

MPJE study plan

8 weeks · About 7 hours per week

Week 1

Federal statutes, regulations, and agency guidance affecting pharmacy practice

  • Build a structural map of federal drug law (FDCA, Durham-Humphrey, Kefauver-Harris, Orphan Drug Act, Hatch-Waxman, FDA Amendments Act) and explain how each amendment changed pharmacy practice

  • Distinguish prescription from nonprescription status and articulate the legal basis for legend drug dispensing and the prescription-only switch process

  • Outline FDA enforcement tools: warning letters, recalls (Class I-III), import alerts, and the distinction between FDA guidance and binding regulation

  • Trace the Drug Supply Chain Security Act transaction-information and verification duties across manufacturer, wholesaler, dispenser

  • Explain REMS elements (medication guides, restricted distribution, patient registries) and the pharmacist's compliance obligations under each element type

Your checkpoint

One-page federal-law timeline plus a 30-item self-quiz scored at 80% or better, with a written log of every missed item and its correct rule

Week 2

Federal statutes, regulations, and agency guidance affecting pharmacy practice

  • Apply the Health Insurance Portability and Accountability Act privacy rule to real pharmacy workflows: minimum necessary, treatment-payment-operations exceptions, and permissible disclosures without authorization

  • Differentiate the Anti-Kickback Statute, the False Claims Act, and the civil monetary penalty rules as they apply to pharmacist incentives, waivers, and discount programs

  • Describe federal compounding and outsourcing-facility requirements under section 503A and 503B, including the prescription-based versus outsourcing-facility distinction

  • Explain pharmacist duties under the Combat Methamphetamine Epidemic Act for scheduled listed chemical products (logbook, daily/lunar sales limits, identification)

  • Identify the federal tamper-resistant prescription pad and Medicaid reimbursement requirements that constrain dispensing

Your checkpoint

Completed comparison chart of the three fraud-and-abuse statutes plus answers to 20 mixed federal-law scenarios, each annotated with the governing authority in one sentence

Week 3

Federal statutes, regulations, and agency guidance affecting pharmacy practice & Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

  • Locate and read the state pharmacy practice act and the board's administrative rules, noting where state law is stricter than federal law and where it defers

  • Map the state board's rulemaking and disciplinary process, including grounds for license discipline, complaint handling, and appeal rights

  • List state-specific prescription requirements: required elements, validity periods, refill limits, oral versus electronic prescriptions, and prescriber verification duties

  • Compare state and federal rules on patient records retention, prescription transfer, and refusal-to-fill obligations

  • Explain the state's pharmacist scope of practice, collaborative practice authority, and any statewide protocol or standing order provisions

Your checkpoint

A state-law quick-reference sheet (no more than two pages) covering prescription validity, records retention, transfers, and disciplinary grounds, checked line by line against the statute and rules

Week 4

Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance & Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements

  • Build a complete controlled-substance schedule table from the state and federal schedules, noting where the state diverges from federal scheduling

  • Explain DEA registration categories, the separate registration rule for each location, and the corresponding state controlled-substance license requirement

  • Apply the prescription rules for Schedule II versus III-V: written, oral, electronic, emergency oral with follow-up, partial fills, refills, and expiration

  • Identify ordering and recordkeeping controls: DEA Form 222 and the electronic equivalent, invoices, biennial inventory, and theft/loss reporting timelines

  • Describe the corresponding-responsibility standard and the red-flag indicators that trigger a pharmacist's duty to resolve before dispensing

Your checkpoint

Closed-book schedule and prescription-rules table completed from memory, then corrected against source, plus 25 controlled-substance scenario questions at 85% or better

Week 5

Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements & Prescription processing, dispensing, labeling, counseling, and patient care obligations

  • Walk through prescription intake to release: verification of prescriber authority, therapeutic and legal review, dispensing error prevention, and final pharmacist verification

  • Specify required label content for both outpatient and inpatient settings, including auxiliary labeling and state-specific additions

  • Explain counseling duties and mandated-offer triggers, documentation of refusal, and counseling exceptions for emergency and inpatient situations

  • Describe refill-too-soon, therapeutic interchange, generic substitution, and substitution-permission rules along with required patient notification

  • Apply prescription transfer and central-fill rules across state lines including controlled-substance transfer limits

Your checkpoint

A validated dispensing workflow checklist with every legal checkpoint labeled by authority, plus five written error scenarios with the correct pharmacist action and documentation

Week 6

Prescription processing, dispensing, labeling, counseling, and patient care obligations & Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance

  • Define the pharmacist's patient-care obligations: medication therapy management eligibility, comprehensive medication review elements, and documentation standards

  • Apply immunization authority rules: protocol requirements, screening, consent, documentation, and reporting to the state immunization registry

  • Explain adverse-event and error reporting duties, including mandatory reporting to the board, the manufacturer, and the federal program

  • Resolve multi-state practice questions: telehealth prescribing, out-of-state prescriber recognition, and dispensing to patients in another state

  • Contrast pharmacist duties in the case of suspected forgery, impairment, or prescription fraud versus outright refusal to fill

Your checkpoint

Two-page patient-care obligations summary plus a scripted counseling and refusal-to-fill dialogue set (three scenarios) reviewed against the statute for accuracy

Week 7

Licensure, registration, certification, and pharmacy operations/inventory management & Compounding, nonprescription and behind-the-counter products, and special distribution channels

  • Assemble the license and registration inventory required for a pharmacy to operate: facility license, individual licenses, DEA registration, controlled-substance license, and any specialized permits with renewal cycles

  • Explain personnel requirements: licensure verification, technician-to-pharmacist ratios, technician certification and registration duties, and intern supervision rules

  • Describe inventory-management legal obligations: perpetual inventory triggers, returns and reverse distribution, destruction and witnessed disposal, and quarantine of recalled stock

  • Apply USP standards and state compounding rules to sterile and nonsterile preparation, including beyond-use dating and documentation

  • Differentiate nonprescription, behind-the-counter, and restricted-distribution channels, and explain recordkeeping for exempt and pseudoephedrine products

Your checkpoint

A comprehensive compliance calendar table listing every license, permit, and inventory/log requirement with its interval and responsible party, plus 20 compounding and OTC questions at 80% or better

Week 8

Federal statutes, regulations, and agency guidance affecting pharmacy practice & Jurisdiction-specific pharmacy statutes, board rules, and regulatory guidance & Controlled substances: scheduling, registration, ordering, recordkeeping, and prescription requirements & Prescription processing, dispensing, labeling, counseling, and patient care obligations & Licensure, registration, certification, and pharmacy operations/inventory management & Compounding, nonprescription and behind-the-counter products, and special distribution channels

  • Synthesize the six domains into a single decision framework that resolves conflicts in favor of the stricter standard

  • Re-drill every previously missed quiz item and confirm the governing rule for each without notes

  • Complete timed mixed-domain practice sets under exam conditions and analyze error patterns by domain

  • Rehearse a rapid-recall review of numbers: retention periods, refill limits, reporting deadlines, ratio limits, and renewal cycles

Your checkpoint

Full-length timed practice exam with a written error-analysis sheet and a final one-page numeric-facts sheet produced entirely from memory

Milestones

Week 2: Explain, without notes, how a federal regulation, an FDA guidance document, and a state rule differ in force, and correctly resolve five conflict-of-law scenarios in favor of the stricter standard

Week 4: Reproduce the controlled-substance schedule table and the Schedule II versus III-V prescription rules from memory with 90% accuracy, and state the theft/loss and inventory timelines without reference material

Week 6: Complete a 40-question mixed set spanning domains 1 through 4 and score at least 80%, with no more than two misses attributable to the same underlying rule

Week 8: Score at least 75% on a full-length timed mixed-domain exam and demonstrate that every missed item on earlier quizzes has been re-answered correctly without notes

MPJE exam day

Your checklist

Authorization to Test (ATT) / exam admission document from NABP

Confirm your ATT is active, the exam window has not expired, and the name on it matches your ID exactly. If your ATT has lapsed, contact NABP before traveling.

Appointment confirmation from the test delivery provider

Bring a printed copy or a screenshot of your appointment confirmation (date, time, testing center address). Confirm the appointment details in your provider account the day before.

Primary government-issued photo ID with signature

Unexpired, physical (not a photo of it), with a signature and name matching your registration. Confirm the exact ID requirements and whether a second form of ID is required with NABP and the test delivery provider before exam day.

Secondary ID, if the provider requires one

Some testing programs require a second form of identification. Verify whether this applies to you directly with NABP or the test delivery provider; do not rely on another candidate's experience.

Your NABP e-Profile login credentials

You will need these to check score reporting and any post-exam requirements. Keep them somewhere you can access after the exam, not written inside study materials you leave behind.

Directions, parking, and transit plan to the testing center

Do a dry run or map the route in advance, and note parking options and building/ suite location. Aim to arrive well before your appointment time; confirm the provider's recommended arrival window (commonly about 30 minutes early, but verify).

Plan for personal items (phone, smartwatch, notes, bag)

Expect to store personal items in a locker or leave them at home or in your vehicle. Phones, smartwatches, notes, and study materials are not permitted in the testing room.

Water and a snack for before or after the exam

These stay outside the testing room. Confirm the provider's policy on accessing personal items during unscheduled breaks.

Light review material kept outside the testing room

If you review in the car or lobby beforehand, do not carry notes, flashcards, or printed state law summaries into the testing room.

A realistic pacing plan written down (mental math only)

The MPJE is 120 questions in 2.5 hours, roughly 75 seconds per question. Plan to flag and move past items you cannot resolve quickly, then return.

Sleep and nutrition plan for the night before

Protect sleep the night before; a sleep-deprived candidate makes more careless errors than a slightly underprepared one.

Plan the day

72 hours before

Confirm appointment date, time, and testing center address in your provider account. Verify your ATT is valid and your name matches your ID. Resolve any discrepancy with NABP or the provider now, not on exam day.

72 hours before

Finish heavy content review. Shift to consolidated summaries of state-specific pharmacy law: dispensing and counseling requirements, controlled substance handling, recordkeeping, and licensure rules that differ from federal baseline.

72 hours before

Check the provider's current security and ID policies, break policy, and what is prohibited in the testing room so nothing surprises you at check-in.

48-36 hours before

Do a practice pacing run: work a set of mixed questions on a timer to calibrate about 75 seconds per item and practice flagging and returning.

24 hours before

Pack your ID(s), appointment confirmation, and directions in one place. Lay out clothing without pockets or bulky items if that helps you move through security quickly.

24 hours before

Do a short, light review of your own summary sheets only. No new topics, no full-length practice exams, no cramming after early evening.

24 hours before

Confirm the alarm, transportation, and backup plan (rideshare, alternate route). Get a full night's sleep.

Morning of

Eat a normal meal and hydrate. Arrive at the provider's recommended time; check in, present ID, and store personal items as directed.

During the test

Read each question stem for the jurisdiction and practice setting. On questions testing a specific state rule, apply that state's rule, not the federal default.

During the test

Answer every question; there is no penalty for guessing on a scored item. Flag uncertain items, keep moving, and revisit if time remains.

During the test

If you take a break, confirm whether the clock stops; assume the clock keeps running unless the provider states otherwise, and keep breaks short.

After the test

Note your completion confirmation and check your NABP e-Profile for score reporting. Do not discuss specific exam content with anyone.

Rules to check

  • Bring original, physical, unexpired identification. Photocopies, expired documents, and photos on a phone are not accepted; confirm the exact accepted ID types with NABP and the test delivery provider before exam day.

  • Your registration name must match your ID exactly. Name mismatches are a common cause of being turned away, and a rescheduled exam may involve a fee.

  • Do not bring notes, phones, smartwatches, earbuds, or study materials into the testing room. Assume any unauthorized item, even if unused, can lead to score cancellation or a misconduct finding.

  • The exam is confidential. Do not reproduce, discuss, or share exam questions or answer content; doing so can void your score and affect your eligibility for licensure.

  • Follow all proctor instructions and testing center security procedures, including pockets, sleeves, and locker use. Cooperate with any security screening.

  • Break access is limited and typically unscheduled; the testing clock generally continues to run. Confirm the specific break policy with the provider.

  • Scores are reported by NABP through your e-Profile, typically after a scoring and validation period rather than immediately at the testing center. Confirm the current reporting timeframe with NABP.

  • If you need to reschedule or cancel, do it through the provider within the allowed window to limit fees; confirm the current rescheduling and cancellation terms with the provider.

MPJE FAQ

How many MPJE practice questions are available?

The practice set has 199 MPJE questions. Each one includes the choices, the correct answer, and an explanation, and the set is free to read with no signup.

How many MPJE flashcards are available?

The flashcard set has 32 MPJE cards. Each card shows the term and its definition.

Which topics does the MPJE study material cover?

The MPJE study material has 6 sections, including Federal Statutes, Regulations, and Agency Guidance, Jurisdiction-Specific Statutes, Board Rules, and Regulatory Guidance, and Controlled Substances: Scheduling, Registration, Ordering, Recordkeeping, and Prescriptions.

What format facts does the catalog list for the MPJE exam?

The catalog lists these item types: multiple choice, computer-based test (CBT) delivered at a commercial testing network, and state/jurisdiction-specific: federal law plus the law of the jurisdiction selected at registration for the MPJE exam.